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ABSTRACT OF THE DISSERTATION 
Mechanism of Obesity Induced Impairment of Reproduction 
by 
Nancy M. Lainez 
Doctor of Philosophy, Graduate Program in Biomedical Sciences 
University of California, Riverside, June 2019 
Dr. Djurdjica Coss, Chairperson 
 
The increase of obesity among US men and women of age 20-39 has resulted in 
social and economic consequences. Obese individuals are at increased risk of developing 
reproductive issues. Obese women present with menstrual irregularities, pregnancy 
complications, and infertility due to anovulation, while obese men present with low 
testosterone and sperm count. Mammalian reproduction is regulated by the hypothalamic-
pituitary-gonadal axis. Gonadotropin releasing hormone (GnRH) neurons, scattered in the 
preoptic area of the hypothalamus, synthesize and secrete GnRH to act on the anterior 
pituitary to stimulate the synthesis and secretion of luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) from gonadotrope cells. LH and FSH then act on the gonads 
to promote steroidogenesis and gametogenesis.  
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Nutritional status exerts their effects on reproduction by modulating GnRH levels.  
Previous studies have reported that metabolic pathways do not directly act on GnRH 
neurons. Pro-inflammatory cytokines, tumor necrosis factor (TNF) α, interleukin (IL)-6 
and IL-1β, which are elevated  in circulation and in the central nervous system (CNS), 
including the hypothalamus, of obese individuals, have been implicated in altering GnRH 
levels in rodents challenged with lipopolysaccharide, but how these cytokines mediate their 
effects is unknown and controversial. Thus, we investigated mechanisms by which 
inflammatory signals influence GnRH neurons and GnRH gene expression to provide 
insight into the etiology of obesity-induced infertility. 
Our studies conducted in C57BL/6J mice demonstrated sex differences in the 
response to diet induced obesity with respect to inflammation and hypothalamic function.  
We proposed neuro-immune mechanisms of obesity induced impairment of reproduction 
whereby neuroinflammation and subsequent decrease in GnRH neuron spine density was 
specific for male mice, while protection in females was independent of ovarian estrogens.  
We also investigated direct effects of neuroinflammation-induced cytokines on GnRH gene 
expression by examining signaling pathways and mechanisms in male mice and in GnRH 
expressing cell line, GT1-7 cells. We identified an additional mechanism of obesity 
induced impairment of reproduction where LIF directly repressed GnRH mRNA via cFOS, 
that is induced in GnRH and other neurons that are proximal to fenestrated capillaries of 
diet-induced obese male mice. 
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Chapter 1: Introduction 
 
1.1  Hypothalamic Pituitary Gonadal Axis 
 The hypothalamus is a forebrain region located below the thalamus. It is delineated   
by the lamina terminalis and optic chiasm rostrally, mammillary bodies caudally, the walls 
of the third ventricle medially and by the internal capsule laterally. The hypothalamus is 
comprised of several nuclei containing neurons that express a number of neuropeptides and 
neurohormones implicated in the regulation of a wide range of homeostatic processes, 
including food intake, thirst, energy expenditure, body weight, circadian rhythms, 
thermoregulation and reproduction [1]. These neurons can project to other brain regions or 
other hypothalamic nuclei, allowing communication between them.  The preoptic area 
(POA), arcuate nucleus (ARC), anteroventral paraventricular (AVPV), are hypothalamic 
nuclei heavily involved in the regulation of reproduction, while the ARC, lateral 
hypothalamus area (LHA) and ventromedial hypothalamic nucleus (VMH) are involved in 
regulating satiety and food intake [1]. The hypothalamus contains several 
circumventricular organs that lack a blood-brain barrier, most notably organum 
vasculosum laminae terminalis (OVLT) located in the rostral region, and median eminence 
(ME) located at the ventral border.  These areas possess specialized arrangements of blood 
vessels called the hypophyseal portal system, with capillary endothelial cells that allow 
diffusion of large molecules in the central nervous system (CNS) where the neurons 
involved in metabolism and reproduction may be able to sense them.  
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 Reproduction is controlled by the hypothalamus-pituitary-gonadal axis. The final 
brain output that regulates reproduction is hypothalamic neuropeptide gonadotropin 
releasing-hormone (GnRH), secreted by a small population of hypothalamic neurons. 
There are about 800 GnRH neurons scattered in the forebrain of a mouse. GnRH neuron 
cell bodies are localized to the preoptic area (POA) and send long axon projections to the 
median eminence, where GnRH is released in a pulsatile manner into the hypophyseal 
portal blood system.  GnRH is carried to the anterior pituitary where it binds to its receptor 
on gonadotrope cells, stimulating the synthesis and secretion of gonadotropin hormones, 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH) [2]. LH and FSH act 
through their receptors located in the gonads to regulate gonadal development and function. 
LH acts on Leydig cells, in males, and theca cells, in females, to promote testosterone 
production in both sexes, and to stimulate ovulation in females. FSH works on Sertoli cells 
to stimulate spermatogenesis via synthesis of androgen binding protein in males, while in 
females FSH acts on granulosa cells to stimulate folliculogenesis prior to antral stage and 
to stimulate estrogen synthesis from testosterone produced by theca cells. Estrogen and 
testosterone feedback at the level of the hypothalamus and pituitary to regulate GnRH, LH, 
and FSH [3]. GnRH neurons integrate afferent neurons, metabolic hormones and sex 
steroids in the regulation of reproduction [3].   
 
 
 
 
 3 
1.2 Obesity Effects on Reproductive Fitness  
Obese individuals are at increased risk of developing reproductive issues.  
According to the world health organization, obesity, defined as a body mass index (BMI) 
of ≥30 kg/m2, is linked to an increased risk of ischemic heart disease, type II diabetes, and 
reproductive disorders for both men and women [4], [5]. Over the past 30 years prevalence 
of obesity has increased steadily with over 30% of men and women classified as obese, 
including those of reproductive age (20-39).  In the recent years, increase in obesity has 
disproportionally affected children and young individuals, which may lead to longer term 
consequences on a number of homeostatic processes, including reproductive function.   
 
1.2.1 Negative Effects of Obesity in Men 
 Previous studies have reported that weight gain and obesity is associated with 
suppression of testosterone and reduced levels of sex hormone binding globulin [6], [7]. In 
obesity, reductions in testosterone is accompanied by reduced levels of LH [6]. Many 
studies are in agreement that sperm number and quality are negatively impacted by obesity 
[8], [4] - [9]. Increased BMIs (>25 kg/m2) in males are associated with lower sperm 
concentration and fewer total spermatozoa compared with subjects with normal BMIs (20 
- 25 kg/m2) [10], [11]. Meta-analysis of 21 reports and a total of 13000 men, associated 
obesity with increased prevalence of azoospermia and oligozoospermia [5].  
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Studies in humans were confirmed using obese Zucker rats that demonstrated 
decreased sperm production and increased sperm DNA fragmentation compared to their 
lean littermates [10], [9]. In addition, sperm binding and fertilization rates during in vitro 
fertilization (IVF) are reduced when the male partner is overweight or obese [12]. Since 
obesity mediated reduction in testosterone is observed with reduced LH levels, and age-
associated reduction in testosterone is accompanied with an increase in LH, due to the 
negative feedback, obesity likely impairs central, hypothalamic function, while age affects 
testicular function [6]. 
 
1.2.2 Negative Effects of Obesity in Women 
Similar to what is observed in overweight and obese men, overweight and obese 
women are more likely to have reduced fertility accompanied by reduced levels of LH [13], 
[4]. Obesity among women include early onset of puberty, menstrual irregularities, 
pregnancy complications, infertility and spontaneous abortions [14], [15]. A previous 
report found that among women seeking to become pregnant, obese women experience 
longer times to conception regardless of age and menstrual cycle patterns [16]. It has been 
established that obese women have lower levels of gonadotropins [17], [18]. A study 
conducted in 25 gynecologically normal and regularly menstruating age matched obese 
women had significantly reduced serum levels of LH [17] consistent with other studies 
where the amplitude of LH was dramatically reduced in obese women compared to controls 
[18]. In a larger study that evaluated 833 women, heavier women had longer cycles and 
lower levels of LH [19].  
 5 
Studies conducted in mammals are consistent with what is observed on obese 
women. In female mice, diet induced obesity resulted in increased estrous cycle length, 
suggesting obese mice ovulated less [20]. Female rhesus macaques placed on western diet 
(WSD) for 6 months, a high calorie and high fat diet, presented with reduced LH pulse 
amplitude [21]. After 14 months on the diet, body fat increased from 2% to 15-19%, and 
LH pulse amplitude remained low [21]. These studies suggest that the level of 
dysregulation may be at the hypothalamus.  
 
1.3 Regulation of GnRH secretion 
1.3.1 Kisspeptin 
 Kisspeptin (KISS), is a 54 amino acid neuropeptide important for the onset of 
puberty and support of reproductive function in the adult. KISS was first shown to be 
critical for reproduction in humans that carry mutation in KISS1 gene and fail to undergo 
pubertal development and are infertile [22], [23].  Intracerebroventricular (ICV) injection 
of KISS in immature female rats caused precocious puberty [24]. ICV [25], intraperitoneal 
(IP) [26], and intravenous [27] injections with KISS elicited robust secretion of LH in adult 
male mice, sheep, and human males respectively.  
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KISS signals through the G protein coupled receptor 54, GPR54 expressed 
throughout the hypothalamus and on GnRH neurons in adult male rat, male and female 
juvenile and adult mice, and male rhesus monkey [28], [26], [25], [29]. While expression 
of GPR54 on GnRH neurons in humans, have not yet been reported, KISS and GPR54 
were immunolocalized and co-expressed with GnRH in the fetal olfactory mucosa and 
FNC-B4 cells, primary culture of human fetal GnRH-secreting neuroblasts [30]. The 
importance of KISS-GPR54 signaling was identified when studies reported that loss of 
function mutation of GPR54 resulted in hypogonadotropic hypogonadism and absence of 
puberty in humans [23]. Consistent with these studies, mice deficient for GPR54 
experience hypogonadotropic hypogonadism, with pituitary gonadotropes that are capable 
of responding to exogenous GnRH, indicating that KISS is upstream of GnRH [22, 23, 
[31].   
In rodents, KISS neurons are found in the AVPV and in the ARC and send 
projections to the POA, where GnRH neurons are abundant [32]. KISS neurons in the 
AVPV project to GnRH cell bodies, while those from the ARC project to GnRH terminals 
[33].  AVPV is a sexually dimorphic area, larger [34] with more KISS neurons in the female 
than in the male [35], while the ARC shows no sex differences in rodents [36]. Similar sex 
differences were reported in humans [37], which may indicate that these two populations 
serve different functions. KISS1 mRNA is increased by estradiol in the KISS neurons in 
the AVPV, and this population is thought to regulate estrogen positive feedback during the 
preovulatory LH surge [38], [39]. In the ARC, estrogen treatments resulted in lower KISS1 
mRNA [38], [39]. Thus, KISS neurons in the AVPV has been suggested to generate the 
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preovulatory GnRH/LH surge in the female [40], while those in the ARC are thought to be 
involved in the negative feedback by estrogen.  
In the adult mammalian brain, GnRH neurons secrete GnRH in a pulsatile manner. 
Since GnRH neurons are scattered in the basal forebrain, significant effort has been made 
to identify the pulse generator that would activate and synchronize dispersed GnRH 
neurons. Previously, rhythmic activity of KISS neurons from the ARC were found to 
coincide with GnRH/LH pulses [36], [41] - [42]. Others reported that mutation of GPR54 
in mice had no effect on hypothalamic production of GnRH peptide GnRH [23]2, 23, [31].   
KISS likely regulates GnRH secretion, but not GnRH peptide production.  
These data suggest  that KISS is a major regulator of GnRH secretion, so much so that 
recent review posited that KISS neurons in the ARC nucleus synchronize GnRH neurons 
and drive the pulsatile secretion of GnRH [41]. 
 
 
1.3.2 Neurotransmitters Glutamate and GABA 
 
 Glutamate is regarded as the main fast excitatory neurotransmitter in the central 
nervous system. The three types of ionotropic glutamate receptors are a-amino-3-hydroxyl-
5-methyl-4-isoxazole-propionate (AMPA), comprised of 4 subunits GluR1-4 and GluR A-
D, N-methyl-D-aspartic acid (NMDA), comprised of subunits NR1-3 with NR1 as the 
obligatory subunit, and kainate-type glutamate receptors comprised of GluK1-5 subunits 
[43]. These receptors are found at the postsynaptic dense (PSD) structure of the neuron 
[44]. PSDs can be found on dendritic spines of many neurons. GnRH neurons not only 
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express all three types of glutamate receptors [45] - [46], but also exhibit spines on the 
soma and primary dendrite [47]. 
 Spontaneous excitatory postsynaptic stochastic current (sEPSC) studies, conducted 
in brain slices from adult male and female mice demonstrated that 50% GnRH neurons 
tagged with GFP exhibit sEPSCs resulting from activation of AMPA/kaintate receptors 
while 31% of GnRH neurons displaying sEPCs was mediated by NMDA receptors, and 
19% resulted from both [48], supporting that GnRH neurons receive glutamatergic input. 
Currents recorded in GnRH neurons located in the AVPV produce a fast rise and decay 
time when evoked by AMPA, while decay time for NMDA is much slower. There are 
studies suggesting the involvement of glutamatergic pathways in puberty onset and in 
evoking preovulatory GnRH surge [49] - [50].  
 The g-aminobutyric acid or GABA, is classically regarded as the inhibitory 
neurotransmitter in the central nervous system. There are three classes of GABA receptors, 
GABAA ligand-gated ion channel, GABAB metabotropic seven-transmembrane domain G-
protein coupled receptor, and GABAC considered a subclass of GABAA. These receptors 
are located on both pre- and post-synaptic membranes. GnRH neurons express both 
GABAA and GABAB receptors with studies reporting both inhibitory and excitatory actions 
of GABA on GnRH/LH secretion. GABAergic neurons in the AVPV express estrogen 
receptors and are thought to play both inhibitory and excitatory roles to regulate the LH 
surge, since following GABA release during the LH surge they exhibit changes in the 
expression of GAD67, the enzyme that converts glutamate into GABA [51] - [52]. Studies 
that focused on the direct action of GABA on GnRH neurons using both GT1-7 cells [53] 
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- [54] and transgenic mice [55] - [56] found that the activation of GABAA receptors excited 
both GT1-7 cells and GnRH neurons in mouse hypothalamic slices. The GABAA receptor 
gates an intrinsic ion channel that mainly passes chloride, thus GABAA receptor activation 
can either inhibit or excite a cell depending on chloride levels. A study that recorded post 
synaptic currents of GnRH neurons in adult fed and fasted transgenic female mice, in 
diestrus, in which green fluorescent protein (GFP) is genetically targeted to GnRH neurons, 
determined that the principal ligand-activated chloride channel in GnRH neurons is 
GABAA receptor [57]. 
This study showed that direct GABA application elicited robust action potentials 
of GnRH neurons, in the presence of high or low chloride levels, from both fed and fasted 
mice. GnRH neurons from fasted female mice had significantly lower post synaptic current 
from fed female mice. This may suggest that in fasted mice, GABAergic drive on GnRH 
neurons is reduced.  
Although studies have shown that activation of GABAA receptors on the soma and 
proximal dendrite GnRH neurons caused action potential discharges and activation of L-
type calcium channels [56], [58]other studies have reported that GABA acts on GnRH axon 
terminals in the ME.  When GABA release near GnRH nerve terminals was activated in 
rats, the estrous cycle was disrupted and fertility was reduced [59]. This suggests that the 
effect GABA on GnRH neurons may depend on where on the neuron GABA receptors are 
activated and on intracellular ion concentration. 
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1.4 Regulation of GnRH gene expression 
GnRH is a peptide hormone composed of 10 amino acids that is elevated in the 
onset of puberty and essential for the reproductive process [60]. The control of GnRH 
synthesis and, as previously discussed, release have been studied heavily. The development 
of GnRH secreting cell lines, GN11 (immature, migratory cells) and GT1-7 (mature, non-
migratory cells) and transgenic mice enabled the investigation of GnRH gene expression 
and the regulation in vitro and in vivo [61], [62]. GnRH promoter contains different 
putative transcription factor-binding sites that are important for basal transcription 
activities. 
The 5’flanking region of the GnRH gene is homologous between human, rats, and 
mice [63]. Specific binding sites for a number of different transcription factors have been 
found within the promoter and enhancer have been identified by studying the rat promoter.  
Neuron-specific activation of the rat GnRH gene is conferred, in culture and in vivo, 
by two upstream evolutionarily conserved regulatory elements: the 300 bp enhancer 
(−1863 to −1571, rodent numbering) and a promoter (−173 to +1). The 173 bp promoter 
upstream of the transcription start site has  about  80%  nucleotide  homology among 
human, rat and mouse [64] - [65]. The 300 bp enhancer provides 50–100-fold activation of 
GnRH gene transcription as compared to the activity of the promoter alone [65]. 
Several transcription factors have been identified to act on the enhancer or promoter 
as regulators of GnRH gene transcription, including the homeodomain proteins Oct-1, 
Six6, SCIP/Oct-6, Dlx2 and Msx1, and Otx2; the zinc finger protein GATA-4; nuclear 
factor-1; and CCAAT/enhancer-binding protein-β  [64 - 66].  
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Octamer transcription factor Oct-1 is a critical regulator of GnRH transcription and 
confers a 20-fold induction of the GnRH gene at the proximal promoter region at -47/-40 
and within the enhancer at −1785 to −1771 bp [67].  Mutation of the Oct-1 binding site 
within −1785 to −1771 bp resulted in 95% reduction in transcriptional activity [67]. Thus, 
Oct-1 is important for basal transcriptional activity of the GnRH enhancer [67]. Within the 
enhancer region, two GATA site, -1710 to -1715 bp and -1743 to -1748 bp, bind two GATA 
factors, GBP-A1/A2 and GBF-B1, which were found to be necessary for full enhancer 
activity [68]. The function of homeodomain proteins may be determined by the interaction 
of cofactors, which can enhance or inhibit the interactions between the homeodomain 
proteins Msx1, a repressor, and Dlx2, an activator, compete for homeodomain ATTA sites 
[69]. Two of these sites are located on the proximal promoter (−41 to −38 bp and −54 to 
−51 bp) and two sites on the enhancer (−1620 to −1617 bp, and −1634 to −1631 bp) [69, 
70]. Specific interactions of transcription regulators with specific cofactors affect the 
activity of the promoter and result in specific targeting of expression of GnRH in GnRH 
neurons. Cofactor, groucho-related gene (GRG) 4 that interacts with Msx/Dlx 
homeodomain factors also interacts with Oct-1 to repress Oct-1-mediated activation [70].  
Cofactors that interact with Oct-1 resulting in activation of GnRH transcription include, 
GRG5, Pbx1b and Prep1 [71, 72]. These antagonistic functions may be important during 
the onset of puberty, when GnRH increases. Knock-out (KO) of Six6 leads to loss of GnRH 
neurons during late development. 
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 The orthodenticle homeobox (Otx) site in the promoter, found to bind Otx2 protein, 
was shown to be important for basal and enhancer driven transcription of the GnRH gene. 
In addition, two Otx2 binding sites, TTATC, -319 to -315 bp and TAATCC, -257 to -252 
bp, were shown to be important for appropriate neuronal expression of GnRH  [66, 73]. 
Other homeodomain protein required for normal GnRH neuron development includes 
Six6.  
A previous study demonstrated that treatment of GT1-7 neurons with human 
chorionic gonadotropin (hCG), a GnRH inhibitor, resulted in an increase in phosphorylated 
Fos, Jun and cAMP response element binding protein (CREB) [74]. Overexpression of Fos 
and CREB inhibited promoter activity in the -3026 to +116 bp construct[74]. The specific 
binding site for FOS and CREB were not identified. We and others have shown that 
repression of GnRH, in GT1-7 cells  is mediated through cFOS [75] - [76]. 12-O-
tetradecanoyl phorbol-12-acetate (TPA) resulted in a dose and time dependent reduction in 
GnRH mRNA expression [77]. Repression of GnRH by TPA was found to be dependent 
on the proximal promoter, which previous studies identified activator protein-1 (AP-1) site 
in this region [76, 78]. It was found that the increase in c-fos and c-jun mRNA levels 
mediated this repression, but did not bind the AP-1 site, and required Oct-1, Prep/Pbx1a 
[77], [76]. In our studies we determined that LIF activated the MAPK pathway specifically 
p38 to repress GnRH, mediated by cFOS. We furthermore, identified the regulatory 
element that mediates this repression. 
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Though the development of GnRH neurons and control of GnRH expression has 
been studied heavily, further investigation is needed to understand the combination of 
transcription factors and the effect of surrounding environment required to fine-tune GnRH 
expression. 
 
1.5 Feeding Circuitry 
 Normal function of the hypothalamic-pituitary-gonadal (HPG) axis, is sensitive to 
nutritional status [79]. States of over- and under- nutrition have resulted in disruption of 
the HPG axis in both humans and rodents. In the CNS, metabolic cues are coordinated by 
anorexigenic proopiomelanocortin (POMC) neurons and orexigenic neuropeptide Y (NPY) 
from the ARC nucleus and orexin from the lateral hypothalamus (LHA) [80]. These 
neurons regulate food intake by sensing levels of leptin and insulin, and it is proposed that 
they convey metabolic status to HPG axis. Though studies have examined the involvement 
of neuropeptides produced by POMC, NPY, and orexin neurons in communicating 
metabolic status to the HPG axis, results remain controversial.  
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1.5.1 POMC 
Pro-opiomelanocortin (POMC) is an anorexigenic precursor found in neurons in 
the ARC that co-express cocaine and amphetamine-regulated transcript (CART). POMC 
neuronal activation reduces food intake and decreases energy expenditure. Melanocortins, 
such as adrenocorticotropic hormone (ACTH) and anorexigenic a-melanocyte-stimulating 
hormone (a-MSH), and orexigenic b-endorphin (b-END) an opioid peptides are products 
cleaved from POMC precursor. The receptors for melanocortins have been classified into 
five subtypes, MC1R, MC2R, MC3R, MC4R, and MC5R. The classical a-MSH receptors 
is MC1R while MC2R is the classical ACTH receptor. Orexigenic b-END act on µ- and k-
receptors.  
While higher levels of leptin and insulin inhibits NPY and orexin neurons, POMC 
neurons are activated by leptin and insulin. POMC neurons express leptin receptors and 
insulin receptors. Mice lacking leptin receptor specifically on POMC neurons are mildly 
obese and hyperleptiemic [81]. When insulin receptors are deleted from POMC neurons, 
there is no observed change in body weight, but when both leptin receptor and insulin 
receptors are deleted from POMC neurons, severe insulin resistance and diabetes results 
[82]. Leptin activates POMC neurons to stimulate the secretion of a-MSH, which in turn 
binds to neurons that express MC4R to suppress appetite. On the other hand, POMC 
neurons release b-END which stimulates feeding. This suggests a more complex role of 
POMC neurons in the regulation of feeding.  
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POMC products, a-MSH and b-END have differential effects on reproduction. 
While a-MSH stimulates lordosis behavior in female rats, b-END inhibits GnRH/LH 
secretion. POMC neurons make direct contact with GnRH neurons in the rat brain ([83]). 
Brain slices from adult female mice where GnRH neurons are genetically linked to green 
fluorescent protein GFP were treated with neuropeptides made by POMC neurons, a-
MSH, b-END, and CART assessed using loose-patch recordings. Firing rate of 69% of 
GnRH neurons were increased with a-MSH. When GnRH neurons were exposed to CART, 
firing rate increased for 25% GnRH neurons a-MSH. b-END application resulted in 
decreased rate of firing in 30% of GnRH neurons [79]. Thus, POMC products have 
opposing effects on a common pathway. 
 
1.5.2 NPY  
Neuropeptide Y (NPY) is an orexigenic neuropeptide synthesized by neurons in the 
ARC and the dorsomedial hypothalamic nucleus (DMH) that are activated during states of 
low energy, such as lactation or starvation. Ghrelin, secreted by the stomach and intestine, 
activate NPY neurons to promote food intake.  NPY signals through G-protein coupled 
receptors, several of these receptor subtypes have been identified, Y1, Y2, Y3, Y4, Y5 and 
Y6. Although NPY can act directly on POMC neurons through its receptor, Y1 [84], studies 
have shown female and male mice that were genetically modified to overexpress NPY, 
Npytet/tet, maintained a similar body weight as WT mice [99].  This same study showed that 
when NPY expression was reduced in these same mice, induced by Dox treatment, no 
difference in food consumption or refeeding responses were observed when compared to 
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control ([85]). This suggests that neuropeptides released by NPY may be playing a 
compensatory role. Previous studies have explored neuropeptides, agouti-related protein 
(AgRP) and g-aminobutyric acid (GABA), released by NPY neurons that originate in ARC 
as potential candidates in the regulation [86], [87]. AGRP was reported to not be required 
for the regulation of energy homeostasis [88] while GABA was shown to inhibit 
anorexigenic POMC neurons [89]. This suggests that NPY is not necessary for maintaining 
normal feeding behavior and that GABA might compensate for the absence for NPY. 
In addition to regulating food intake, NPY neurons and the neuropeptides they 
release have been reported to have both stimulatory and inhibitory roles on the GnRH/LH 
system. In a study conducted in ovariectomized rhesus macaques, intracerebroventricular 
administration of NPY inhibited LH pulses, while local administration of NPY into the 
median eminence stimulated the release of GnRH [90]. In C57BL6 mice and rats, chronic 
central administration of NPY resulted in hypogonadism, while acute ICV administration 
of NPY stimulated the release of LH form ovarian steroid-primed ovariectomized rats [91], 
[92]. These opposing effects of NPY on GnRH, are thought to be due to the complex 
interplay of neuropeptides released by NPY neurons, AgRP and GABA, and the NPY 
receptors activated.  
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Previous studies have shown that NPY neurons, including those that express AGRP 
and GABA, from the ARC make contacts with the majority GnRH neurons [93, [86], [93], 
[94]. Brain slices from adult female GnRH green fluorescent protein (GFP) mice were 
prepared for loose patch recording experiments treated with AgRP resulted in reduced 
activity of 10% of GnRH neurons and stimulation of 25% of GnRH neurons [79]. In 
ovariectomized rhesus monkeys central infusion of AgRP into the third ventricle resulted 
in decreased LH pulse frequency [95].  
Studies conducted in ovariectomized  female Sprague-Dawley rats that were 
primed with estradiol and progesterone and received GABAA receptor agonist, muscimol, 
intracerebroventricularly, had no effect on LH release [92]. When NPY was given to these 
rats alone, LH release was stimulated [92]. When GABAA receptor agonist was added with 
NPY, NPY stimulated LH release was reduced [92]. This suggests that the co-release of 
NPY and GABA by NPY neurons may inhibit the release of LH. On the other hand, others 
have reported that in sections prepared for postsynaptic current recordings of GnRH 
neurons from fasted adult female mice showed GnRH currents were reduced compared to 
fed mice, while slices from fed mice treated with NPY decreased postsynaptic current 
frequency. This suggests, since NPY is increased with food deprivation, and GABA 
induced action potentials of GnRH neurons from fed mice, and NPY reduced postsynaptic 
current frequency of GnRH neurons from these mice, that NPY is involved in the decrease 
of excitatory GABA secretion on GnRH neurons [96]. 
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Other studies investigated the effect of NPY receptors activation on GnRH neuron 
activity. Y1/Y2/Y5 receptor agonist, pNPY, resulted in reduced firing of 46% of GnRH 
neurons, but a highly selective Y5 receptor agonist, [cPP1-7, NPY19-23, AL31, Aib32, 
Gln34]-hPP, had no effect on GnRH neuron excitability [79]. To further examine NPY 
receptor activation on GnRH neurons, an agonist for receptors Y1/Y4/Y5, with high 
affinity for Y4 and Y5, was shown to inhibit 30% and stimulate 50% of GnRH neurons. A 
Y4 agonist, rPP, increased firing rate in 50% of GnRH neurons. This suggests that NPY 
may suppress GnRH neurons through Y1 and stimulate through Y4 receptors [79]. To date, 
only receptor Y1 and Y5 have been reported to be expressed on GnRH terminals and cell 
bodies, respectively [93], [94]. While this study showed that Y5 agonist had no effect on 
GnRH neurons from female mice, others have reported that infusions of Y5 agonists, 
PYY3-36, in the lateral ventricle of male Sprague-Dawley rats and male C57BL/6J mice 
result in reduced levels of LH, testosterone, and reduced testicular weight [97]05, [91]. 
Together these studies describe a complex regulatory role of NPY neurons on GnRH 
neuron activity.  
 
1.5.3 Orexin 
The hypothalamic neuropeptide, orexin, is mainly known for its role in sleep and 
wakefulness and is also involved in the control of feeding and drinking. Neurons that 
express orexin are found in the lateral hypothalamus (LHA) and send projections 
throughout the brain, including the POA where GnRH cell bodies are found and to the 
mediobasal hypothalamus and ME where GnRH axon terminals project.  
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There are two forms of orexin, orexin A and orexin B, with orexin A being more 
physiologically potent due to its resistance to degradation. Similar to NPY, orexin has both 
stimulating and inhibiting effects on GnRH/LH secretion. A previous study demonstrated 
that GnRH neurons express orexin 1 receptors, and that orexin neurons contact GnRH 
neurons from both male and female rats [98]. Tissue explants from male and female rats in 
proestrus show that orexin A stimulates GnRH release from the hypothalamus, while in 
diestrus or low estrogen states orexin A is inhibitory. Expression of orexin receptor 1 was 
also observed in GT1-7 cells and treatment with orexin resulted in increased GnRH mRNA 
expression and stimulated the release of GnRH [99].  
 In addition, studies using both rat and primate brains have shown that orexin 
neurons not only express leptin receptors, but also express receptors for NPY, such as Y1 
and Y4 [100], [98]. Orexin neurons were also shown to make synaptic contact with NPY 
neurons in the ARC and vice versa [100]. These studies suggest that orexin may be 
stimulating NPY release and enhancing feeding behavior. On the other hand, since orexin 
neurons express NPY receptors, this suggest NPY could exert some of its effects via orexin 
neurons in the LHA. 
In summary these studies describe a complex neuronal network linking metabolism 
and reproductive fitness, whereby POMC, NPY, and Orexin neurons mediate effects of 
metabolic cues on GnRH neurons. However, none of these studies explain negative effects 
of obesity. 
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1.6 Adipose Tissue as an Endocrine Organ  
Adipose tissue (AT) has been established as a regulator of systemic nutrient and 
energy homeostasis. Adipose tissue (AT) is composed of adipocytes, connective tissue, 
and non-adipocyte cells including macrophages, immune cells, endothelial cells, 
preadipocytes and fibroblasts. AT is involved in the regulation of appetite, energy balance, 
immunity, insulin sensitivity, angiogenesis, blood pressure, and lipid metabolism.  
The adipocyte is the chief storage of triglycerides and communicates with different organ 
systems through the secretion of polypeptides, called adipokines, including leptin and 
adiponectin.  
 
1.6.1 Leptin 
 Leptin is a protein product of the obese (ob) gene, which is secreted by adipocytes 
and functions as a satiety factor to regulate food intake by signaling to the brain. Leptin 
provides a link between metabolism and reproduction, and studies suggest that these two 
systems are integrated in the hypothalamus. Leptin receptor KO mice experience delayed 
onset of puberty in males and females and infertility [101]. Both male and female mice that 
lacked leptin (ob/ob mice), resulted in sterility, and leptin treatment restored reproduction 
[102], [103]. Leptin communicates nutritional status to the central nervous system via 
orexigenic neuropeptide Y (NPY) and anorexigenic proopiomelanocortin (POMC) neurons 
in the ARC of the hypothalamus where KISS neurons are found [80]. Studies have shown 
that lean ovariectomized ewes with reduced levels of KISS1 gene expression, ICV 
 21 
treatment with leptin resulted in partial restoration of KISS1 mRNA, while ICV treatment 
with kisspeptin peptide reduced POMC and increased NPY gene expression [104].  
 Both POMC and NPY neurons have shown to express leptin receptor mRNA [101], 
[105], [106] and send projections to KISS neurons [107]. Studies have shown leptin to 
exert its effects on GnRH release by acting through KISS neurons [108], [104]. Studies 
conducted in castrated adult male C57BL6 mice, leptin deficient ob/ob mice, and leptin 
treated ob/ob mice, showed KISS1 mRNA expression levels in the ARC decreased in leptin 
deficient mice and increased in leptin treated mice. This study also showed that KISS1 
mRNA expressing cells expressed leptin receptor [108]. In ovariectomized, fasted and fed, 
Wistar female rats using pull push perfusion technique leptin induced GnRH, LH, α-MSH, 
and PRL secretion in a dose dependent manner [109]. This study proposed that leptin acts 
directly on both GnRH cell bodies and axons to stimulate the secretion of GnRH and 
suggested that α-MSH may play an intermediary role in stimulation of GnRH secretion by 
leptin. Others have shown that specific leptin receptor KO in GnRH neurons of female and 
male mice did not affect fertility compared to control [101]. In addition, deletion of leptin 
receptor from hypothalamic KISS neurons in mice did not affect puberty onset or fertility 
[110]. Thus, suggesting that leptin signaling on GnRH or KISS neurons is not required for 
onset of puberty and fertility. Though there may be conflicting data implicating the direct 
or indirect action of leptin on GnRH neurons to regulate fertility, it is likely that 
intermediary peptides carry out these actions [79], [111]. 
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In obesity, leptin levels are elevated, and even though studies in mice show that 
leptin treatment in ob/ob mice, that lack leptin, resulted in reversal of obesity and reduced 
calorie intake, obese humans are resistant to leptin. Thus, the biological efficacy of leptin 
in obesity may be limited.   
 
1.6.2 Adiponectin  
 Adiponectin is secreted by AT and acts to increase insulin sensitivity, fatty acid 
oxidation, energy expenditure, and reduction of liver gluconeogenesis. Unlike leptin, 
adiponectin levels are negatively correlated with body mass index, specifically abdominal 
fat accumulation [112]. Thus, adiponectin is thought to contribute to insulin insensitivity. 
Fat deposits in two main depots, visceral and subcutaneous.  Subcutaneous fat accounts for 
80% of all body fat. Visceral fats accounts for 10-20% of total body fat in men and 5-8% 
in women. Visceral deposits produce more adipokines than subcutaneous deposits. 
Adiponectin is produced in visceral fat, but its levels are decreased with abdominal obesity 
[113], [114]. A study analyzing levels of adiponectin in serum, showed that non-obese and 
obese women have higher levels of adiponectin than men [115], [116], which may be 
explained by the fact that men have higher percent visceral fat than females.  
 Previous studies suggest that adiponectin is implicated in reproduction. 
Adiponectin suppressed GnRH secretion in immortalized GnRH neuron cell line, GT1-7 
[117]. In the female mouse brain adiponectin decreased GnRH neuron activity [118]. In 
male rats, adiponectin inhibited testosterone secretion [119]. Although male patients with 
metabolic syndrome have lower levels of adiponectin, they still present with reduced levels 
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of testosterone suggesting another level of regulation is responsible. In primary rat 
granulosa cells, adiponectin, had no effect on the secretion of progesterone and estradiol 
production, but in the presence of insulin like growth factor (IGF), secretion of 
progesterone and estradiol were increased [120]. Thus, in females, adiponectin may be 
important during pregnancy, when levels of IGF, progesterone and estrogen increase. 
 
1.7 Obesity as a chronic inflammatory state 
Obese adipose tissue is characterized by inflammation and progressive infiltration 
by macrophages as obesity develops [121]. Visceral deposits contain a higher density of 
macrophages than subcutaneous deposits. The number of macrophages present white 
adipose tissue correlated with BMI (in humans), adiposity and adipocyte size in both 
humans and mice, and their functional activity is proportional to the degree of obesity 
[122]. In obesity, adipocytes begin to secrete low levels of tumor necrosis factor alpha 
(TNF) α, which can stimulate preadipocytes to produce monocyte chemoattractant protein-
1 (MCP-1, or CCL2 chemokine) [121]. Endothelial cells also secrete MCP-1 in response 
to cytokines. CCL2 chemokines is a ligand for CCR2 that recruits monocytes and 
macrophage activation [121]. Increased secretion of leptin may also contribute to 
macrophage accumulation by stimulating transport of macrophages to adipose tissue and 
promoting adhesion of macrophages to endothelial cells, respectively.  
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1.7.1 Macrophages in adipose tissue 
In lean individuals, macrophages resemble an M2 phenotype that secrete anti-
inflammatory cytokines such as arginase which blocks inducible nitric oxide synthase 
(iNOS) activity [123]. With the development of obesity there is a change in macrophage 
phenotype to M1. M1 macrophages secrete pro-inflammatory cytokines TNFα, IL-6, and 
IL-12, and generate reactive oxygen species such as nitric oxide via activation of iNOS 
[124]. Adipose macrophage density increases with obesity, which is likely due to invasion 
of macrophages from the bloodstream. Invasion and activation of macrophages into 
adipocytes initiates production of inflammatory cytokines. 
 
1.8 Neuroinflammation 
 Hypothalamic inflammation is becoming increasingly recognized as a pathological 
characteristic of obesity in animals and humans. Increased inflammation in the central 
nervous system (CNS) of obese individuals may contribute to neuropathologies associated 
with diseases of the CNS, such as cerebral ischemia and dementia [125], [126]. 
Characterizing cellular interactions underlying these inflammatory responses may have 
important consequences for systems regulated by the hypothalamus, such as reproduction. 
The central nervous system (CNS) has long been regarded as an immune-privileged site 
due to the blood brain barrier (BBB), yet evidence  supporting a role for classical pro-
inflammatory cytokines interleukin (IL)-1β, tumor necrosis factor (TNF) α, IL-6, 
involvement in both the normal physiology of the nervous system and pathology is 
accumulating [127]. Inflammatory cytokines may play a role in neuronal migration, cell 
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proliferation, and synaptic activity. Glial cells of the brain, microglia and astrocytes, are 
involved in maintaining homeostasis in the CNS [128], [129]. Microglia are resident 
immune cells that survey the parenchyma and act as scavengers of debris, while astrocytes 
maintain the BBB and support synapse function [128], [129]. Upon stimulation, microglia 
mediate neuronal and glial injury and death through production of cytokines that can trigger 
astrogliosis and recruit cells of the immune system, such as peripheral macrophages [130]. 
Obese individuals have increased levels of pro-inflammatory cytokines, IL-1β, IL-6, and 
TNFα in circulation, which can be attributed to the increase in adipose tissue (AT) and 
accompanied macrophage infiltration [20, 131]. 
 
1.8.1   TNFa and IL-1b 
In the CNS TNFa  and IL-1b have both homeostatic and pathophysiological roles. 
In the healthy CNS, TNFa  regulates synaptic plasticity, learning and memory, sleep, food 
and water intake and astrocyte-mediated synaptic strength [132]. In several CNS diseases, 
microglia upregulate TNFa expression contributing to excitotoxicity by inhibiting 
glutamate transport on astrocytes and by increasing localization of ionotropic glutamate 
receptors to synapses [133]. 
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In the hypothalamus, in the OVLT, during infection, TNFa and IL-1b  mediate the 
physiological and behavioral responses in sickness such as, inducing fever, inhibiting food 
intake, causing nausea and fatigue [133-135]. TNFa and IL-1b mediate their effects 
through activation of downstream signaling molecules: nuclear factor-kappa B (NFk-B), 
Janus kinase and signal transducers and activators of transcription pathway (JAK-STAT) 
and mitogen activated protein kinases (MAPK) [136-138]. TNFα and IL-1β also activate 
transcription factors to produce IL-6. 
 
1.8.2 IL-6  
 IL-6 was originally identified as a factor that induced maturation of B-cells into 
antibody producing cells.  IL-6 plays a role in the regulation of immune reactions and 
inflammation, but is also involved in regenerative activities [139], [140]. IL-6 bound to 
membrane-bound IL-6 receptor or the soluble form of the IL-6 receptor interact with gp130 
to signal. In naïve states, IL-6 contributes to normal function of the brain regulating neuron 
function and neurogenesis. IL-6 deficiency leads to reduced sensitivity of sensory neurons, 
resulting in decrease in temperature sensitivity in IL-6 KO mice. In the CNS, neurons, 
astrocytes, microglia and endothelial cells are potential sources of IL-6. In models of brain 
injury and infection, induced by LPS, or diet-induced obesity, IL-6 is upregulated where it 
is involved in modulating inflammation, apoptosis, and oxidative stress to promote 
recovery and healing. Previous studies report more rapid healing and recovery after 
traumatic brain injury in mice that overexpressed IL-6 in the CNS [141]. IL-6 KO mice 
showed increase oxidative stress and impaired neuroglial activation [142], suggesting a 
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neuroprotective role of IL-6 in brain injury. Although LPS induces IL-6 in both astrocytes 
and microglia, TNFa and IL-1b have been shown to induce IL-6 production from 
astrocytes and not microglia, in in vitro studies [143]. Consistent with these studies, 
preliminary studies in our lab has shown that in diet-induced obesity, astrocytes produce 
IL-6.  
 
1.8.3 Leukemia inhibitory factor (LIF) 
 LIF is a member of IL-6 family that is induced during inflammatory response [144]. 
However, its functions are not limited to inflammation: LIF has been demonstrated to play 
a crucial, non-redundant role in embryo implantation in both mice and humans [145-147]. 
LIF also maintains stem cells and regulates differentiation of germ cells [148, 149]. In the 
brain, LIF regulates neuronal function and neuronal response to injury [150-152]. LIF 
binds its specific receptor, which, similarly to the other members of the IL-6 family, 
recruits and signals through the GP130 signals transducer, activating JAK-STAT pathway 
[146]. However, LIF was not previously analyzed in obesity. Our data are first show 
increased levels of LIF mRNA in the hypothalamus of diet induced obese mice [20]. 
 Neuroendocrine cells express various cytokine receptors and TNFa, IL-1b and IL-
6 are likely to play a central role in the inhibition of the reproductive axis observed during 
severe illness. Very little is known about the precise mechanisms involved and available 
data regarding the effects of individual cytokines on the neuroendocrine reproductive axis 
remain controversial. LPS challenged rodents exhibited reduced levels of LH and GnRH 
mRNA, diminished release of LH and GnRH, and increased levels of pro-inflammatory 
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cytokines, such as TNFa, IL-1b and IL-6 in the circulation [153] - [154]. Centrally 
administered cytokines also provoked reduced LH and GnRH levels, but the mechanism 
whereby these cytokines mediate their effects is unknown [155] - [156]. Our previous study 
postulated that impairment of GnRH neurons stems from reduction in spine density and 
consequently the connectivity of the GnRH network [20]. However, GnRH neurons 
express several cytokine receptors [157] and inflammation-induced cytokines may directly 
regulate intracellular signaling pathways in the GnRH neurons. 
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Abstract 
Increasing prevalence in obesity has become a significant public concern. 
C57BL/6J mice are prone to diet-induced obesity (DIO) when fed high-fat diet (HFD), and 
develop metabolic syndrome, making them a good model to analyze mechanisms whereby 
obesity elicits pathologies. DIO mice demonstrated profound sex differences in response 
to HFD with respect to reproductive hormone levels and hypothalamic function. We 
determined that males are prone to DIO, while females are resistant. Ovariectomized 
females, on the other hand, are susceptible to DIO, implying protection by ovarian 
hormones. Males, but not females, exhibit changes in hypothalamic neuropeptide 
expression. Surprisingly, ovariectomized females remain resistant to neuroendocrine 
changes, showing that ovarian hormones are not necessary for protection. This study 
elucidates a potential mechanism of obesity-induced impairment of hypothalamic function 
whereby obese males exhibit reduced levels of excitatory post-synaptic protein, PSD, 95. 
And exhibit reduced synapses in GnRH neurons. Changes that are potentially responsible 
for diminished levels of gonadotropin hormones, testosterone, and sperm numbers, which 
corresponds to the observations in obese humans. Taken together, our data implicate sex-
specific differences in obesity-induced impairment of the hypothalamic function with 
potential consequences for reproduction and fertility.  
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Introduction 
Over half of the US population is classified as overweight and a full third is 
classified as obese [158]. The number of obese people has increased steadily over the last 
30 years [159]. This increase in obesity has coincided with an increase in co-morbidities, 
such as type 2 diabetes, cardiovascular disease, stroke, and hypothalamic disorders, 
including reproductive disorders that cause infertility [160-163]. Deleterious effects of 
obesity on fertility include irregularities in menstrual cycles, abnormalities in the oocyte 
development, anovulation, and increased risk of miscarriages in women [163]; and inferior 
sperm quality, reduced sperm quantity, and lower testosterone levels in men [164]. 
Currently, 18% of couples require assisted reproductive technologies to become pregnant 
[165], a portion of which may stem from widespread obesity [166, 167]. Although several 
hypotheses have been put forth [168-172], mechanisms whereby obesity negatively affects 
reproductive function are unknown.  
The hypothalamus in the basal forebrain controls feeding and satiety, 
thermoregulation, thirst, circadian rhythms, metabolism, and mammalian reproduction. In 
the control of reproduction, the hypothalamic decapeptide gonadotropin-releasing 
hormone (GnRH) is the final brain output that regulates expression and secretion of 
gonadotropins, luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the 
anterior pituitary gonadotropes [173], which in turn stimulate steroidogenesis and 
gametogenesis in the gonads [3, 174]. In the rodent hypothalamus, the majority of GnRH 
cell bodies are scattered in the preoptic area surrounding organum vasculosum laminae 
terminalis (OVLT), while secretion occurs at the terminals in the median eminence (ME). 
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Both OVLT and ME are circumventricular areas with a leaky blood-brain barrier, whereby 
hypothalamic neurons perceive changes in the circulation and neuropeptides reach the 
portal circulation [175]. GnRH secretion is synchronized by upstream regulatory neuronal 
populations [176]. These regulatory neurons integrate sex steroid feedback from the gonads 
[177], and external or environmental factors, such as stress [178, 179], and exposure to 
endocrine disruptors [180, 181]. Metabolic stimuli and energy status, such as anorexia 
nervosa, excessive exercise, malnutrition, and obesity are also integrated with reproductive 
function at the level of the hypothalamus [169-172, 182, 183]. However, since metabolic 
signals do not influence GnRH neurons directly [101, 184, 185], we investigated other 
potential mechanisms.  
To analyze the effects of obesity-induced inflammation on reproductive function 
we used diet-induced obese (DIO) mice. Significant strain differences were observed in 
response to high-fat diet (HFD) and A/J, FVB/NJ and BALB/cJ strains are resistant to DIO, 
while DBA/2J and C57BL/6J gain weight [186-188]. The C57BL/6J mouse is a particularly 
faithful model of the human metabolic syndrome because it develops obesity, 
hyperinsulinemia, hyperglycemia, and hypertension, when allowed ad libitum access to a 
HFD [189, 190]. Herein, we demonstrate profound sex differences in response to HFD. 
Specifically, C57BL/6J male mice exhibit resultant decrease in the number of synaptic 
spines on GnRH neurons and reduction in GnRH mRNA levels. On the other hand, female 
mice are resistant to neuroendocrine changes, and this protection is independent of ovarian 
hormones.  
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Materials and Methods 
Animals 
C57BL/6J mice were obtained from Jackson Laboratory at 3 weeks of age. After a 
week acclimatization, they were randomly assigned to the high-fat diet fed group (HFD, 
D12492, 60% kcal from fat; Research Diet, New Brunswick, NJ) and control group (Ctr, 
D12450J, 10% kcal; Research Diet, New Brunswick, NJ) for an indicated number of 
weeks. Animals were maintained under a 12-hour light, 12-hour dark cycle and received 
food and water ad libitum. All experiments were performed with approval from the 
University of California Animal Care and Use Committee and in accordance with the 
National Institutes of Health Animal Care and Use Guidelines using 16-week-old animals 
(3 weeks before weaning, 1 week normal chow, and 12 weeks high fat or control diet) 
unless indicated otherwise. During the week between weaning and experimental diet, while 
fed normal chow, all animals were handled daily by experienced personnel to assure 
habituation and minimize stress [191].  
 
Estrous cyclicity-Starting at 12 weeks of the Ctr or HFD, female mice were assessed for 
estrous cycle stage with daily vaginal smears for 6 weeks. Vaginal lavage was performed 
daily (between 9-10 am) by flushing the vagina with distilled H2O. Collected smears were 
mounted on glass slides and examined microscopically for cell types. Both groups of 
animals were handled daily, at the same time of day, to account for any potential stress that 
handling may cause. Estrous cycle stages determined during the first week of vaginal 
smears were not included in the analysis to allow for acclimatization. Female mice on 
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control diet exhibited normal 4-5 day-long estrous cycles, indicating habituation to 
handling. Estrous cycle length was calculated as the length of time between two successive 
occurrences of estrus. For subsequent studies, females were estrous cycle staged and tissue 
samples collected in diestrus between 9-11 am. 
 
Sperm count-After 12 weeks on the respective diet, males were sacrificed between 9-11 
am. The epididymides were dissected, macerated, and then incubated in 1 ml DMEM at 
room temperature for 30 minutes with shaking. Sperm was cleared with a 70 µm cell 
strainer, diluted with sterile water and counted with a hemocytometer. 
 
GnRH-GFP mice were kindly provided by Dr. Suzanne Moenter [192]. Males and 
females were analyzed separately to determine sex differences. At least 10 animals per sex 
per genotype were analyzed, unless indicated otherwise for a specific analysis in the 
materials and methods section. Statistical differences (p < 0.05) between control (Ctr) and 
high fat diet (HFD) fed mice were determined by Student’s T-test or 2-way ANOVA where 
appropriate, and Tukey’s test for multiple comparison. 
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Hormone Analysis 
For serum collection, mice were sacrificed between 9-11 am by isoflurane 
inhalation and blood was obtained from the inferior vena cava. The blood was left to 
coagulate for 15 minutes at room temperature, and then centrifuged at 2000 RCF for 15 
minutes for serum separation. Hormone assays were performed by the University of 
Virginia, Ligand Core. The University of Virginia Center for Research in Reproduction 
Ligand Assay and Analysis Core is a fee-for-service core facility and is supported in part 
by the Eunice Kennedy Shriver NICHD/NIH U54-HD28934 Grant. LH was measured by 
the ultra-sensitive mouse LH ELISA, an in-house method. The capture monoclonal 
antibody (anti-bovine LH beta subunit, 518B7) is provided by Janet Roser, University of 
California. The detection polyclonal antibody (rabbit LH antiserum, AFP240580Rb) is 
provided by the National Hormone and Peptide Program (NHPP). HRP-conjugated 
polyclonal antibody (goat anti-rabbit) is purchased from DakoCytomation (Glostrup, 
Denmark; D048701-2). Mouse LH reference prep (AFP5306A; NHPP) is used as the assay 
standard. Intra-assay coefficient of variation is 2.2% and inter-assay coefficient of variation 
is 7.3% at the low end of the curve. Functional sensitivity is 0.016 ng/ml. FSH was assayed 
by RIA using reagents provided by Dr. A.F. Parlow and the National Hormone and Peptide 
Program, as previously described [193]. Mouse FSH reference prep AFP5308D was used 
for assay standards. Steroid hormone levels were analyzed using validated commercially 
available assays, information for which can be found on the core’s website: 
http://www.medicine.virginia.edu/research/institutes-and-programs/crr/lab-
facilities/assay-methods-page and reported in [194]. Limits of detection were 2.4 ng/ml for 
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FSH, 3 pg/ml for estradiol, and 10 ng/dL for testosterone. Intra- and inter-assay coefficients 
of variation were 6.9%/7.5%, 6.0%/11.4% and 4.4%/6.4% for the FSH, estrogen (E2) and 
testosterone (T), respectively. Ten animals per group were used for each hormone analysis. 
Statistical differences in hormone levels between Ctr and HFD groups were determined by 
Student’s T-test, and Tukey-Kramer HSD for multiple comparisons using JMP software 
(SAS Institute; Cary, North Carolina).  
 
Histological analyses and immunohistochemistry 
Following Ctr or HFD mice were anesthetized, perfused with 20 ml PBS and 20 ml 
4% paraformaldehyde; and tissues collected. Brains were fixed in 4% paraformaldehyde, 
embedded in paraffin, and cut to 20 µm. Slides were deparaffinized in xylene and 
rehydrated. Antigen unmasking was performed by heating for 10 minutes in a Tris-EDTA-
0.3% Triton X and endogenous peroxidase was quenched by incubating for 10 minutes in 
0.3% hydrogen peroxide. Slides were then blocked with 20% goat serum and incubated 
with primary antiserum against GnRH (1:1000 PA1-121, Thermo Sci.) or Iba-1 for 
microglia (1:300 cat # 019-19741, Wako) overnight at 4°C. After PBS washes, slides were 
incubated with biotinylated goat anti-rabbit IgG (1:300, BA-1000, Vector Laboratories, 
Burlingame, CA) for 30 minutes. The Vectastain ABC elite kit (Vector Laboratories) was 
used per manufacturer's instructions, after which the DAB peroxidase kit was used for 
colorimetric staining. Slides were dehydrated in ethanol and xylene, and cover-slipped with 
Vectamount (Vector Laboratories).  
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Hypothalami from GnRH-GFP mice were sectioned to 100 µm sections and 
sections containing organum vasculosum laminae terminalis (OVLT) where GnRH 
neurons are located, stained for GFP to visualize GnRH neurons. Slides were blocked with 
20% goat serum and incubated with primary antibodies against GFP (1:5000 raised in 
chicken), at 4°C for 48 h. After PBS washes, slides were incubated with FITC/Alexa 488 
goat anti-chicken IgG (1:300, Molecular Probes, Eugene, OR) for 30 minutes. Secondary 
antibody-only controls were performed to determine antibody specificity.  Images were 
obtained using confocal Leica SP2 microscope. To determine spine density, we followed 
our established protocol as published before [195-199], with modifications that correspond 
to previously described procedures for analysis of spines in GnRH neurons [47, 200]. 
Spines, that were identified as protrusions from the soma or axon greater than 1 µm, were 
counted in the individual neurons where at least 75 µm of the axon proximal to soma can 
be observed using z-stack. The full length of every GFP-labeled GnRH neuron, including 
soma and the visible length of the main process, was imaged and analyzed using confocal 
Leica SP2 microscope. Images were encoded for blind analysis.  
Spine numbers were quantified by scrolling through the series of captured images 
in the z-stack using LAS X software and counted for each GFP-labeled GnRH soma and 
along the 75 µm length of axon, at 15-µm intervals.  We counted at least 3 individual 
neurons from 4 different sets of mice marked by hand and using Neurolucida program 
(MBF Bioscience, Vermont). 
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Western blot  
Whole cell lysates were obtained from the dissected hypothalami from Ctr and HFD 
fed mice and after protein determination, the same amount of protein was run on SDS-
PAGE, transferred on nitrocellulose membrane and probed for: Postsynaptic density 
protein 95 (PSD-95; 1:1000, Cat #3409, Cell Signaling), Synaptophysin (SYPH; 1:1000, 
cat. #4329, Cell Signaling), neuronal marker, Microtubule-associated protein 2 (MAP2; 
1:5000, cat #ab5392, Abcam) or b-tubulin (1:1000, cat #sc-9104, Santa Cruz 
Biotechnology). Bands were quantified using ChemiDoc imaging system (Bio-Rad, 
Hercules, CA). 
 
qPCR analyses 
Hypothalami were dissected, total RNA extracted and reverse transcribed using 
Superscript III (Invitrogen, CA). qPCR was performed using an iQ SYBR Green supermix 
and an IQ5 real-time PCR machine (Bio-Rad Laboratories, Hercules, CA) with primers 
listed in Table 1 under the following conditions: 95°C for 15 min, followed by 40 cycles 
at 95°C for 20 sec, 56°C for 30 sec, and 72°C for 30 sec. The amount of the gene of interest 
was calculated by comparing the threshold cycle obtained for each sample with the 
standard curve generated in the same run. Replicates were averaged and divided by the 
mean value of the beta-2-microglobulin (B2M) housekeeping gene in the same sample 
using DDCt method. Preliminary studies analyzing GAPDH, Ywaz, TBP and B2M 
housekeeping genes determined that B2M doesn’t change with diet and was subsequently 
used for normalization. After each run, a melting curve analysis was performed to confirm 
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that a single amplicon was generated in each reaction. Statistical differences in expression 
between genotypes were determined by Student’s T-test, and Tukey’s HSD for multiple 
comparisons using JMP software (SAS Institute; Cary, North Carolina). 
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Table 2.1 Antibodies used for western and immunohistochemistry 
Antibody Species Dilution Provider, cat # and RRID 
GFP chicken  1:5000 Abcam, ab13970; AB_300798 
PSD-95 rabbit  1:2000 Cell Signaling, 3409; AB_1264242 
Synaptophysin (SYPH) rabbit 1:1000 Cell Signaling, 4329; AB_1904154 
MAP2 chicken  1:5000 Abcam, ab5392; AB_2138153 
GnRH rabbit 1:1000 ThermoFisher, PA1-121; AB_325077 
b-tubulin rabbit  1:1000 Santa Cruz Biotechnology, sc-9104; AB_2241191 
 
Table 2.2 Primers used for qPCR  
Primers Forward Reverse 
Gnrh (GnRH) CTACTGCTGACTGTGTGTTTG CATCTTCTTCTGCCTGGCTTC 
Avp (AVP) ACACTACGCTCTCCGCTTGT CGAAGCAGCGTCCTTTGC 
Pomc (POMC) CAGTGCCAGGACCTCACC CAGCGAGAGGTCGAGTTTG 
B2m (beta-2-
microglobulin 
TGACCGGCCTGTATGCTATC
CA 
CAGTGTGAGCCAGGATATA
GAAAGAC 
Gapdh TGCACCACCAACTGCTTAG GGATGCAGGGATGATGTTC 
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Results 
Ovarian Hormones Protect Female C57BL/6J Mice from Diet-Induced Obesity 
C57BL/6J male and female mice were placed on high-fat diet (HFD) or control diet 
(Ctr) one week after weaning and their weights measured twice a week. As demonstrated 
previously [182], male mice gained weight on HFD, while female mice were resistant to 
diet-induced obesity (DIO) and required longer exposure to HFD to exhibit the same 
weight difference from mice on control diet (Fig. 2.1A, male; Fig. 2.1B, female). 
Preliminary studies indicated that females exposed to the HFD for the same length of time 
as males do not exhibit adverse effects of obesity illustrated bellow, while much longer 
exposure would increase the risk of confounding our results with negative effects of ageing; 
thus, we opted to keep the females on the HFD until they reach similar weight gain as 
males. To determine if ovarian estrogens, or other ovarian hormones, play a role in this sex 
difference, we ovariectomized (OVX) the females at 4 weeks of age and placed them on 
the HFD and Ctr. OVX females became susceptible to DIO (Fig. 2.1C). These results 
indicate that ovarian hormones are protective of DIO.  
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Figure 2.1: 1. Ovarian hormones provide resistance to diet-induced obesity in female 
C57Black/6J mice.  Ten C57BL/6J mice per group were placed on control (Ctr,10 
kcal%fat, Research Diet) or high fat diet (HFD, 60 kcal%fat Research Diet) with the same 
sucrose levels, at 4 weeks of age. Their weights were recorded twice a week (A, males; B, 
females). C, ♀ OVX, female mice were ovariectomized at weaning and one week later, at 
4 weeks of age placed on diets. 
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Ovarian Hormones are not Necessary for the Protection from Diet-Induced Obese 
Changes in Hormone Levels 
Following 12 weeks on diets for males and OVX females, which gain weight at the 
same rate as males, and 19 weeks for unmodified females, we measured gonadotropin 
hormone and sex steroid hormone levels. Male mice on HFD exhibited 57% lower 
luteinizing hormone (LH), 35% lower follicle-stimulating hormone (FSH), and 40% lower 
intra-testicular testosterone levels (Fig. 2.2A). Consequently, HFD males had 50% fewer 
sperm in their epididymides (Fig. 2.2A), 22% lower seminal vesicle weight, which is 
dependent on the level of testosterone, while testis weight was unaffected (data not shown). 
Female mice exhibited longer estrous cycles (4.6 days, controls and 6.4 days, HFD), but 
LH, FSH or estradiol level (E2) in diestrus were not significantly changed (Fig. 2B). Thus, 
female mice, although obese as a result of prolonged exposure to HFD, do not exhibit 
changes in gonadotropin hormone levels.  LH and FSH levels in OVX females were 
significantly higher than LH and FSH in unmodified females due to the lack of negative 
feedback (compare 2.2B and 2.2C), which confirms that ovariectomy was successful. 
However, neither LH nor FSH in OVX females were affected by diet (Fig. 2.2C). Thus, 
there are profound sex differences and females are resistant to diet-induced changes in 
reproductive hormones. Additionally, these results demonstrate that ovarian hormones 
contribute to resistance to obesity, but are not necessary for the protection from hormonal 
changes exhibited by female mice.  
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Figure 2.2: Reproductive hormones are lower in obese male mice, while both 
unmodified and ovariectomized females are protected from diet-induced changes. 
Male mice (A) on the HFD have reduced levels of luteinizing hormone (LH), follicle-
stimulating hormone (FSH) and intra-testicular testosterone (T), and fewer sperm. Female 
mice (B) lack changes in LH, FSH and estrogen (E2), but exhibit longer estrous cycles. 
Ovariectomized (OVX) females (C) are protected from hormonal changes similarly to 
unmodified females, indicating that the ovarian hormones are dispensable for protection. 
Differences (*, p< 0.05) between control (Ctr, gray bars) and high fat diet (HFD, black 
bars) were determined by Student’s T-test followed by Tukey’s HSD test. 
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Ovarian Hormones are not Necessary for the Protection from Diet-Induced Obese 
Changes in GnRH mRNA Levels 
Since LH levels are strictly regulated by GnRH neuropeptide from the 
hypothalamus, GnRH (Gnrh) expression was analyzed and revealed that male mice on 
HFD exhibited 46% reduced levels of Gnrh mRNA. To analyze specificity of repression, 
additional neuropeptides were assessed, and we determined that Pomc (POMC, 
proopiomelanocortin) mRNA was increased by 132%, while Avp (arginine vasopressin) 
mRNA was unchanged (Fig. 2.3A). Neither unmodified or OVX female mice, on the other 
hand, exhibited diet-induced changes in Gnrh mRNA level, although OVX females 
exhibited ~10-fold higher Gnrh mRNA levels compared to unmodified females due to the 
lack of negative feedback (Fig. 2.3B, C). These results again illustrate sex specific DIO-
induced alterations in the neuropeptide gene expression in the hypothalamus, independent 
of the presence of ovarian hormones.  
To determine whether a reduction in Gnrh mRNA levels in male mice stems from 
fewer GnRH neurons after exposure to HFD, we analyzed GnRH neuron number and 
detected no difference between diets (Fig. 2.4A). We also detected no difference in 
response to diet in GnRH neuron axon targeting to the median eminence (Fig. 2.4B). Thus, 
decrease in Gnrh mRNA levels correlates with the reduction in LH, testosterone and sperm 
count in male mice following HFD.  
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Figure 2.3: Hypothalamic peptides expression is affected with HFD. A, Male mice on 
HFD had 46% lower expression of Gnrh mRNA and 132% higher Pomc while Avp was 
not affected. B, Female mice did not exhibit changes in Gnrh, but had increased Pomc 
mRNA. C, There was no change in Gnrh expression in ovariectomized (OVX) females.  * 
indicates difference between Ctr (gray bars) and HFD (black bars), determined by 
Student’s T-test followed by Tukey’s HSD test. 
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Figure 2.4: GnRH neuron number or axon targeting is unchanged in DIO mice. 
Coronal sections (A, top) and median eminence (B, bottom) were stained from Ctr and 
HFD fed male mice with anti-GnRH antibodies. No diet-mediated changes in GnRH 
neuron number, nor axon targeting were detected. 
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Decrease in PSD95 and in GnRH neuron spines density in the hypothalamus of obese 
male mice. 
Given that we detected no changes in the number of GnRH neurons, we next 
determined if there are synaptic changes in the hypothalami of HFD male mice and 
specifically GnRH neurons. Subsequent dysregulation of GnRH neurons, which can 
explain reduced GnRH, LH and testosterone levels in male mice on the HFD.  
We first investigated levels of synaptic molecules in the hypothalamus of mice fed 
control or HFD. Western blot analyses revealed lower levels of excitatory post-synaptic 
density (PSD) 95 protein in the hypothalami of HFD male mice, while no changes were 
seen in the overall levels of the pre-synaptic protein synaptophysin (SYPH), usually 
detected in both excitatory and inhibitory pre-synaptic sites (Fig. 2.5A). In contrast, 
PSD-95 and synaptophysin levels were unchanged in the hypothalami of female mice on 
HFD as compared to Ctr females (Fig. 2.5B). Our results show changes in synaptic protein 
levels in the hypothalamus of male mice that are susceptible to DIO, but not neuro-
inflammation resistant female mice.  
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Figure 2.5: Decreased levels of PSD-95 synaptic protein in the hypothalami of male 
mice on the HFD. Western blot using hypothalamic lysates indicate lower levels of post-
synaptic density protein 95 (PSD-95), but not of pre-synaptic marker synaptophysin 
(SYPH) in males (A) but not in females (B). * indicates statistical significance p<0.05 
determined by Student’s t-test and Tukey’s posthoc analysis, after quantification of PSD-
95, neuronal marker MAP2 and housekeeping control  -tubulin. 
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We then wanted to analyze synapses of specifically GnRH neurons. To do so, we 
placed GnRH-GFP mice [192] on the Ctr or HFD for 12 weeks and analyzed spine density, 
since changes in the number of spines have been linked to alterations in neuron 
connectivity [195-199]. Spine density was analyzed in the GnRH-GFP neurons of the Ctr 
and HFD male mice, using the method described previously [47]. Spines were identified 
as protrusions, 1 µm – 5 µm, from the soma or from the proximal axon of these mostly 
unipolar neurons [201]. By scrolling through the z-stack obtained by confocal microscopy, 
we counted the spines on the soma and along the first 75 µm of the length of axon at 15-
µm intervals. GnRH neurons from male mice on Ctr exhibited the same number of spines 
on the soma and in each of the 15 µm segments as determined before [200]. GnRH neurons 
from HFD male mice exhibit fewer spines, especially in the region of the axon that is 45 
µm proximal to soma (Fig. 2.6). Therefore, obese male mice following HFD exhibit 
neuroinflammation and lower number of spines that may indicate reduced connectivity of 
the GnRH neurons, which in turn may lead to reduction in LH, testosterone and sperm 
numbers.  
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Figure 2.6: GnRH neuron spine density is lower in male mice on HFD. A, Coronal 
sections of the preoptic area in the hypothalamus of the GnRH-GFP mice following control 
and HFD were stained for GFP (green) to allow for spine count. B, Spines, identified as 
protrusions indicated with white arrows in A, were counted in the soma and in the visible 
length of the main axon in 15 µm intervals, which are indicated in the graph in comparison 
to the distance from the soma.  * indicates statistical significance p<0.05 determined by 
one-way ANOVA followed by Tukey’s posthoc analysis. 
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Discussion 
  Herein we report several novel findings: we identify sex differences underlying the 
neuroendocrine response to diet-induced obesity (DIO), and that ovarian hormones protect 
from DIO, but are dispensable for female resistance to neuropeptide and hormonal changes; 
we uncover a potential mechanism of obesity-induced impairment of hypothalamic 
function whereby obese males exhibit lower number of synaptic proteins, which may 
underlie negative effects of obesity on reproductive function. 
 Sex differences in response to DIO were reported before in mice and in rats [202]. 
Based on these studies and observations in menopausal women it was hypothesized that a 
lack of estrogen increased adiposity, whereas estrogen replacement diminished it. Increase 
in adiposity following ovariectomy and removal of ovarian estrogen was observed in 
rodents [203, 204] and in monkeys [205]. Our results concur that ovarian estrogen is 
protective from DIO, but do not support the assumption that ovarian estrogen is protective 
from hormonal and immunological changes. Hormonal and immune changes have not been 
examined in response to DIO in unmodified and ovariectomized (OVX) females before. It 
was assumed that hormonal changes would follow weight gain in females after 
ovariectomy, however our data indicate that is not the case. We demonstrate that females 
are protected from hormonal and immune changes regardless of the gonadal status. Sex 
differences we observe may stem from variety of other factors, besides ovarian estrogen. 
In fact, extra-ovarian estrogen may play a role since the Cyp19a1 gene, which encodes for 
aromatase that mediates estrogen synthesis, is expressed in other tissues, especially the 
brain and adipose tissue. Brain-produced estrogen may regulate GnRH neuron function 
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[206], while estrogen synthesis in adipose tissue may regulate deposition in various depots 
[207]. A few studies have analyzed the effects of the high fat diet (HFD) on the 
gonadotropin hormones in mice concentrating on females, since they determined that 
females have longer estrous cycles, findings our results support [182, 208, 209].  
 Due to the significant differences of various mouse strains to DIO, it is difficult to 
draw a direct comparison between some of these studies and ours, if other studies used a 
different strain or mixed strain mice [209]. Several studies identified significantly different 
responses to HFD and some strains, such as BALBc and FVB, were surprisingly resistant 
to DIO [186]. In DBA and C57BL/6J strains, that are prone to DIO, sex differences vary. 
Females of the DBA strain are prone to DIO, have lower pregnancy rates and lower Gnrh 
mRNA [188], while C57BL/6J females are resistant to DIO, as we have also shown herein. 
C57BL/6J mice, used in our study, are most often used in DIO studies since they develop 
insulin resistance and metabolic syndrome that matches human condition [189, 190]. 
Reproductive hormones analyses in DIO C57BL/6J mice determined that diestrus females 
do not exhibit changes in LH, which agrees with our results [208]. However, preovulatory 
levels of LH are lower following HFD, also aligning with the longer estrous cycles in our 
studies [182]. While male mice exhibited lower FSH in both of our studies, employing the 
new ultra-sensitive assay we also detected decreased LH levels. Therefore, male mice have 
lower LH, testosterone and sperm count likely due to lower Gnrh mRNA and reduced 
number of spines in the GnRH neuron. Lower Gnrh mRNA expression is a consistent 
finding in mice fed HFD. Repression of Gnrh mRNA in DIO mice has been reported 
previously [182, 188], supplemental information). Interestingly, another report analyzing 
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obesity-induced genome-wide changes in the brain, detected GnRH as one of the most 
repressed genes [210]. As stated above, acute cytokine infusion in the hypothalamus also 
represses Gnrh expression [211], suggesting that DIO repression of Gnrh mRNA may be 
mediated by increased cytokine concentration. Our studies agree that DIO diminishes Gnrh 
mRNA, and further demonstrate reduction in spine density in GnRH neurons. This may 
indicate that Gnrh expression may be regulated in an activity-dependent manner [212, 213] 
or that Gnrh gene may be repressed via activity-independent mechanisms. Activity-
dependent GnRH gene regulation by afferent neurons has been implied. Hypothalamic 
factors involved in reproductive function, such as RFamide-related peptide 3 (RFRP-3), a 
mammalian gonadotropin-inhibitory hormone ortholog; senktide, a neurokinin B receptor 
agonist; and oxytocin; elicit changes in LH serum levels, not only via alterations of GnRH 
secretion but by modifications of Gnrh transcription [214-216]. On the other hand, GnRH 
neurons express cytokine receptors [157], and Gnrh may be repressed via activation of 
cytokine receptor pathways. 
 Reduction in GnRH spine density may indicate lower neuron excitability. A 
decrease in synapses following HFD was reported previously in the arcuate nucleus in both 
NPY and POMC neurons, which are widely studied neuronal populations in response to 
DIO, since they comprise feeding and satiety circuitry in the hypothalamus [217]. 
Specifically, elimination of inhibitory synapses on POMC neurons and excitatory synapses 
on NPY neurons was described. Reduction in inhibitory synapses may lead to increased 
POMC expression that was previously reported [217] and is consistent with our findings. 
Synaptic stripping, reduced levels of synaptic proteins and fewer spines following diet-
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induced obesity in male C57BL/6J mice were observed in hippocampal neurons as well 
[218]. A decreased performance of HFD mice in cognitive tasks was attributed to the loss 
of synapses, fewer dendritic spines and a decrease in synaptic proteins in the prefrontal 
cortex [219]. Since number of spines and the levels of PSD-95 synaptic protein are linked 
to neuronal connectivity, fewer spines and reduced levels of synaptic proteins, may indicate 
changes in neuronal activity. It was postulated that either estrogen induces changes in a 
number of synapses on POMC neurons, since sex differences were detected in the previous 
study as well [220]; or that leptin is involved in synapse remodeling, since leptin is elevated 
in obesity and targets POMC neurons [217].  
 Our studies also demonstrate that GnRH neurons have fewer spines and lower Gnrh 
mRNA expression. Diminished Gnrh mRNA transcription and reduction in GnRH neuron 
activity may contribute to lower LH levels, reduced testosterone and diminished sperm 
numbers. Previous studies analyzing crosstalk between metabolism and reproductive 
function determined that GnRH neurons may integrate obesity-induced changes in glucose 
directly [221], but changes in insulin [184] and leptin [101, 185] are most likely relayed 
indirectly via neuronal afferents that synapse to GnRH neurons.  
In this manuscript, we show that GnRH neurons may also mediate the effects of 
obesity-induced synaptic changes on reproductive function.  Future studies will determine 
if synaptic changes result in changes in the secretion of the neuropeptide that regulates 
gonadotropin hormone levels and reproduction. Herein, we examine hormonal parameters 
to identify sex-specific effects of obesity on neuroendocrine function. 
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Abstract 
Increasing prevalence in obesity has become a significant public concern. 
C57BL/6J mice are prone to diet-induced obesity (DIO) when fed high-fat diet (HFD), and 
develop chronic inflammation and metabolic syndrome, making them a good model to 
analyze mechanisms whereby obesity elicits pathologies. DIO mice demonstrated 
profound sex differences in response to HFD with respect to inflammation. First we 
demonstrated that males on HFD had heavier visceral fat pads compared to females on 
HFD.  Microglial activation and peripheral macrophage infiltration is seen in the 
hypothalami of males, while females are protected from the increase in inflammatory 
cytokines regardless of the presence of ovarian hormones. Strikingly, the anti-
inflammatory cytokine IL-10 is increased in the hypothalami of females but not males. This 
study elucidates a potential mechanism of obesity-induced impairment of hypothalamic 
function whereby obese males exhibit reduced levels of excitatory post-synaptic density 
protein, PSD, 95 , reported in chapter 2, located in the areas exhibiting macrophage 
infiltration. Taken together, our data implicate neuro-immune mechanisms underlying sex-
specific differences in obesity-induced impairment of the hypothalamic function. 
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Introduction 
 Over half of the US population is classified as overweight and a full third is 
classified as obese [158]. The number of obese people has increased steadily over the last 
30 years [159]. This increase in obesity has coincided with an increase in co-morbidities, 
such as type 2 diabetes, cardiovascular disease, stroke, and hypothalamic disorders [160-
163]. Obesity is characterized by chronic inflammation, in addition to changes in metabolic 
markers [222]. Increased adiposity elicits an increase in inflammatory cytokines in the 
circulation [223, 224], such as: tumor necrosis factor (TNFa, and interleukins, IL-1b, IL-
6 [131], primarily due to macrophage infiltration to adipose tissue and their subsequent 
activation. Inflammatory cytokines have been demonstrated to negatively affect 
hypothalamic function [225]. 
 To analyze the effects of obesity-induced inflammation on reproductive function 
we used diet-induced obese (DIO) mice. Significant strain differences were observed in 
response to high-fat diet (HFD) and A/J, FVB/NJ and BALB/cJ strains are resistant to DIO, 
while DBA/2J and C57BL/6J gain weight [186-188]. The C57BL/6J mouse is a particularly 
faithful model of the human metabolic syndrome because it develops obesity, 
hyperinsulinemia, hyperglycemia, and hypertension, when allowed ad libitum access to a 
HFD [189, 190]. Specifically, C57BL/6J male mice exhibit neuroinflammation. On the 
other hand, female mice are resistant to inflammatory changes.  
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Materials and Methods 
Animals 
C57BL/6J mice were obtained from Jackson Laboratory at 3 weeks of age. After a 
week acclimatization, they were randomly assigned to the high-fat diet fed group (HFD, 
D12492, 60% kcal from fat; Research Diet, New Brunswick, NJ) and control group (Ctr, 
D12450J, 10% kcal; Research Diet, New Brunswick, NJ) for an indicated number of 
weeks. Animals were maintained under a 12-hour light, 12-hour dark cycle and received 
food and water ad libitum. All experiments were performed with approval from the 
University of California Animal Care and Use Committee and in accordance with the 
National Institutes of Health Animal Care and Use Guidelines using 16-week-old animals 
(3 weeks before weaning, 1 week normal chow, 12 weeks high fat or control diet) unless 
indicated otherwise. During the week between weaning and experimental diet, while fed 
normal chow, all animals were handled daily by experienced personnel to assure 
habituation and minimize stress [191].  
For fluorescently labeled microglia, CX3CR1-GFP mice were obtained from 
Jackson labs (strain 005582) and randomly placed on the respective diets at 4 weeks of age 
to analyze change in microglia morphology. Doubly fluorescent GFP and RFP transgenic 
mice obtained after crossing CX3CR1-GFP (strain 005582) and CCR2-RFP (strain 
017586), and heterozygous mice for both alleles were used to distinguish monocyte 
recruitment to the hypothalamus from resident microglia. Statistical differences (p < 0.05) 
between control (Ctr) and high fat diet (HFD) fed mice were determined by Student’s T-
test or 2-way ANOVA where appropriate, and Tukey’s test for multiple comparison. 
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Cytokine Analysis 
For serum collection, mice were sacrificed between 9-11 am by isoflurane 
inhalation and blood was obtained from the inferior vena cava. The blood was left to 
coagulate for 15 minutes at room temperature, and then centrifuged at 2000 RCF for 15 
minutes for serum separation. Cytokine levels in serum and hypothalamic protein lysates 
were measured using Luminex MagPix instrument and mouse ProcartaPlex 7 plex 
(Affymetrix eBioscience, San Diego, CA). Statistical differences in hormone levels 
between Ctr and HFD groups were determined by Student’s T-test, and Tukey-Kramer 
HSD for multiple comparisons using JMP software (SAS Institute; Cary, North Carolina).  
 
Flow cytometry 
Microglial activation and immune cell influx into the hypothalamus and prefrontal 
cortex were characterized as previously described [226].  Tissues from the hypothalamus 
and cortex from each mouse was processed separately as part of a 5-mouse cohort per 
group, with each experiment repeated 3 times. In brief, mice were perfused with ice cold 
PBS, brains rapidly removed and hypothalami and prefrontal cortex cell suspensions were 
generated by mechanical dissociation and applied to a discontinuous 1.03/1.088 percoll 
gradient.  Cells were collected from the interface, blocked with anti-CD16/CD32 (1:300, 
553141, BD Biosciences, San Jose, CA), and incubated with anti-CD45 APC-eFluorÒ 780 
(1:300, 47-0451, eBioscience, San Diego, CA) and anti-CD11b PerCP-Cyanin5.5 (1:300, 
45-0112, eBioscience, San Diego, CA) in PBS, 5% EDTA, 0.4% BSA. Sytox™ Green 
dead stain (30 nM, S-34860, ThermoFisher, Chino, CA) was used to exclude dead cells 
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and flow analysis performed using BD LSR II Flow Cytometer. Results were analyzed 
using FlowJo software (Tree Star, Inc.) and statistical differences were determined by 
Student’s T-test and Tukey’s posthoc test.  
 
Histological analyses and immunohistochemistry 
To visualize GFP-labeled microglia from CX3CR1-GFP mice, and activated 
macrophages labeled red and microglia labeled green from CCR2-RFP x CX3CR1-GFP 
mice, after 12 weeks of Ctr or HFD mice were anesthetized, perfused with 20 ml PBS 
followed by 20 ml of 4% paraformaldehyde; brains were post-fixed in 4% 
paraformaldehyde, frozen in OCT, and cut to 20 µm sections using Leica cryostat. 
Endogenous fluorescence was visualized with Leica microscope.  
 
qPCR analyses 
Hypothalami were dissected, total RNA extracted and reverse transcribed using 
Superscript III (Invitrogen, CA). qPCR was performed using an iQ SYBR Green supermix 
and an IQ5 real-time PCR machine (Bio-Rad Laboratories, Hercules, CA) with primers 
listed in Table 1 under the following conditions: 95°C for 15 min, followed by 40 cycles 
at 95°C for 20 sec, 56°C for 30 sec, and 72°C for 30 sec. The amount of the gene of interest 
was calculated by comparing the threshold cycle obtained for each sample with the 
standard curve generated in the same run. Replicates were averaged and divided by the 
mean value of the beta-2-microglobulin (B2M) housekeeping gene in the same sample 
using DDCt method. Preliminary studies analyzing GAPDH, Ywaz, TBP and B2M 
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housekeeping genes determined that B2M doesn’t change with diet and was subsequently 
used for normalization. After each run, a melting curve analysis was performed to confirm 
that a single amplicon was generated in each reaction. Statistical differences in expression 
between genotypes were determined by Student’s T-test, and Tukey’s HSD for multiple 
comparisons using JMP software (SAS Institute; Cary, North Carolina). 
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Table 3.1 Antibodies used for immunohistochemistry and FLOW cytometry 
Antibody Species Dilution Provider, cat # and RRID 
Iba-1 rabbit 1:300 Wako, 019-19741; AB_839504 
CD45 APC-eFluor 780 rat  1:300 eBioscience, 47-0451 (clone 30-F11), AB_1548781 
CD11b PerCP-Cy5.5 rat 1:300 eBioscience, 45-0112 (clone M1/70), AB_953558 
 
Table 3.2 Primers used for qPCR 
Primers Forward Reverse 
Il6 (IL-6) TTCTCTGGGAAATCGTGGAAAT 
TCCAGTTTGGTAGCATCCA
TCA 
Tnfa (TNFa) ATGTCTCAGCCTCTTCTCATTCC 
GCTTGTCACTCGAATTTTG
AGAA 
Lif (LIF) ATGTGCGCCTAACATGACAG TATGCGACCATCCGATACAG 
Il10 (IL-10) GCTGGACAACATACTGCTAACC 
ATTTCCGATAAGGCTTGGC
AA 
B2m (beta-2-
microglobulin 
TGACCGGCCTGTATGCTATC
CA 
CAGTGTGAGCCAGGATATA
GAAAGAC 
Gapdh TGCACCACCAACTGCTTAG GGATGCAGGGATGATGTTC 
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Results 
Diet-Induced Obese Male C57BL/6J Mice Have Heavier Gonadal Fat Depots than 
Diet-Induced Obese Females 
In chapter 2, C57BL/6J female mice were resistant to diet-induced obesity (DIO) 
and required longer exposure to HFD to exhibit the same weight difference from mice on 
control diet (Fig. 2.1A, male; Fig. 2.1B, female). Thus, we wanted to analyze adipose tissue 
deposition by measuring fat depots. We dissected inguinal fat pad from subcutaneous 
depots, and gonadal fat pad from visceral fat depots, from one side of each animal. Fat pad 
weights were then compared between Ctr and HFD in both males and females. Weight 
comparison of fat pads from Ctr and HFD-fed mice indicates that both males (Fig. 3. 1A) 
and females (Fig. 3.1B) deposit fat in both subcutaneous (inguinal) and gonadal fat depots, 
since fat pads from either depot were heavier in HFD than controls animals. When we 
compared males to females, Ctr males had significantly heavier subcutaneous fat pads and 
gonadal fat pads than Ctr females (compare Fig. 3.1A and 3.1B). HFD fed males had 
significantly heavier gonadal fat pads than HFD females. Given the individual weight 
difference and profound sex differences in size, we also compared fat depots after 
normalizing fat pad weight to total body weight. There was a significant difference in 
normalized weight between gonadal fat pads in Ctr males compared to gonadal fat pads in 
Ctr females, indicating that male mice fed low-fat control diet exhibit higher visceral 
adiposity than females (Fig. 3.1C, indicated with a pound sign). We did no detect sex 
differences between other fat depots. Comparison of fat pads between control and HFD 
revealed preferential fat accumulation in select depots. Significantly, there was a difference 
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in subcutaneous fat pad from HFD female mice compared to subcutaneous fat pad from 
Ctr females, even after normalizing to the body weight (Fig. 3.1C, asterisk), implying that 
females preferentially increase adiposity in the subcutaneous depot. Therefore, 
examination of fat pads may demonstrate that male mice have higher visceral adiposity in 
control conditions, which corresponds to observations in humans. On the other hand, 
female obesity may lead to preferential increase in subcutaneous fat, which exhibits less 
adverse health outcomes [202].      
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Figure 3.1: Ovarian hormones provide resistance to diet-induced obesity in female 
C57Black/6J mice.  Ten C57BL/6J mice per group were placed on control (Ctr,10 
kcal%fat, Research Diet) or high fat diet (HFD, 60 kcal%fat Research Diet) with the same 
sucrose levels, at 4 weeks of age. A. Following exposure to their respective diets, mice 
were sacrificed and subcutaneous (subcut.) fat depots and gonadal fat depots removed from 
one side of each animal and weights recorded (B, males; C, females). F, fat depot weights 
from D and E was normalized to the whole body weight for each animal.  
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Sex-specific differences in inflammatory cytokines in the circulation and the 
hypothalami of HFD-fed mice.  
Obesity is characterized by hyperleptinemia, hyperinsulinemia, hyperlipidemia, 
hyperglycemia, and chronic inflammation. Significant effort has been devoted to determine 
the effects of increased leptin, insulin, fatty acids, or glycose on GnRH neuronal function 
without clear outcomes [171]. We analyzed inflammatory cytokine levels following DIO 
in our mice and determined that inflammatory cytokines were elevated in the circulation 
as well as in the hypothalami of obese mice. There was no difference in serum levels of 
interleukin-6 (IL-6) between males, unmodified females or ovariectomized females on 
control diet (compare Fig. 3.2A, 3.2B and 3.2C), and all three groups exhibited 
significantly elevated serum IL-6 following HFD. Increased IL-6 in the serum of HFD-fed 
male mice (Fig. 3.2A) was previously demonstrated [227]. IL-6 levels were also increased 
in the hypothalamic lysates, at the protein and mRNA levels, indicating that IL-6 was 
induced locally in the hypothalami of the DIO mice. Additionally, hypothalamic IL-6 was 
increased in both male and female mice (Fig. 3.2B, C). However, increased cytokine levels 
were not detected in the cortex of neither male nor female mice (data not shown), indicating 
that neuroinflammation is specific for the hypothalamus.  
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Figure 3.2: Interleukin-6 (IL-6) is increased in the serum and the hypothalamus of 
both male and female mice. Following Ctr (gray bars) and HFD (black bars) serum and 
hypothalami were collected from male (A), unmodified female (B) and ovariectomized 
(OVX) female mice (C). Cytokine levels in serum and hypothalamic protein lysates were 
measured using Luminex MagPix instrument and mouse ProcartaPlex 7 plex (Affymetrix 
eBioscience, San Diego, CA), while mRNA was assayed with qPCR.  * indicates 
significant difference (p<0.05) determined with a T-test and Tukey’s posthoc comparison.  
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We sought to identify cytokines that may exhibit sex differences in response to 
HFD. Tumor necrosis factor (TNF) a and leukemia inhibitor factor (LIF) were examined, 
since shown to increase in DIO [122]. There was no sex difference in TNFa or LIF levels 
in serum of Ctr males and Ctr unmodified females, while removal of ovaries significantly 
increased TNFa concentration, but not LIF, in the serum of Ctr OVX females compared to 
unmodified Ctr females. TNFa and LIF increased specifically in male mice on HFD in the 
serum (3-fold or 300% and 4.83-fold or 483%, respectively), hypothalamic protein levels 
(112% and 155.6%, respectively) and mRNA expression levels in the hypothalamus 
(TNFa, 161% and LIF, 200%; Fig. 3.3A), but were not changed in the cortex (data not 
shown); nor in unmodified or OVX female mice (Fig. 3.3B, C). Therefore, IL-6 was 
increased in both sexes solely in the hypothalami, while TNFa and LIF are induced 
specifically in the hypothalami of male mice. Furthermore, while OVX females became 
susceptible to DIO, they remain protected from the increase in TNFa and LIF 
inflammatory cytokines in the hypothalamus.  
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Figure 3.3: Tumor necrosis factor (TNF)a and leukemia inhibitory factor (LIF) are 
increased specifically in the male mice regardless of the presence of ovarian estrogens. 
Serum and hypothalami were collected from male (A), unmodified female (B) and 
ovariectomized (OVX) female mice (C) following Ctr and HFD. Cytokine levels in serum 
and hypothalamic protein lysates were measured using Luminex MagPix instrument and 
mouse ProcartaPlex 7 plex (Affymetrix eBioscience, San Diego, CA), while mRNA was 
assayed with qPCR.  Difference (*, p<0.05) between Ctr (gray bars) and HFD (black bars) 
were determined by Student’s T-test followed by Tukey’s HSD test. 
 
 
 
 71 
To explain possible protection of female mice, we analyzed anti-inflammatory 
cytokines. Female mice on Ctr diet exhibit significantly higher concentration of anti-
inflammatory IL-10 than Ctr male mice (3.7 pg/ml female, 1.3 pg/ml male, Fig. 3.4) in the 
hypothalamus, while IL-10 was below detection limit in the serum in both sexes. Exposure 
to HFD decreased level of IL-10 protein by 50.2% and Il10 mRNA by 28% in male mice; 
however, HFD increased IL-10 protein to 188% and Il10 mRNA to 165% in the female 
hypothalami (Fig. 3.4). These results indicate that following HFD, inflammatory cytokines 
are increased, while anti-inflammatory cytokines are decreased in male hypothalami 
compared to the male mice on control diet. In contrast, female mice on HFD increase anti-
inflammatory IL-10 concentration in their hypothalami, while lacking heightened 
inflammatory response.  
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Figure 3.4: IL-10 is higher in female mice. IL-10 protein was higher in the hypothalami 
of female mice than male mice, and below detection in the serum in both sexes. After 
exposure to the HFD, IL-10, both protein and mRNA, decreased in males and increased in 
females. Statistical significance (*) between Ctr (gray bars) and HFD (black bars) were 
determined by Student’s T-test followed by Tukey’s test. 
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Regional differences in microglia activation in the hypothalamus.  
Microglia activation in response to the HFD in the arcuate nucleus of the 
mediobasal hypothalamus has been demonstrated previously [228-231]. Using CX3CR1-
GFP mice on Ctr and HFD, we also observed changes from ramified cell body with longer 
processes, to amoeboid, rounded cells body morphology with retracted processes, 
indicating activation of the microglia in the arcuate nucleus, (Fig. 3.5A, top panels). These 
morphological changes were not observed in the female mice (Fig. 3.5A, bottom panels). 
Quantification of CX3CR1-GFP positive cells demonstrated that there is no difference in 
the number of cells between Ctr males and Ctr females. Exposure to HFD increases the 
number of GFP-labeled cells in the arcuate nucleus in males, but not in females.    
Identification of an increase in cell number in the arcuate nucleus in male mice on 
HFD prompted investigation of the regional changes in the number of Iba-1 positive cells 
(Iba-1, is expressed by the microglia in the brain and activated bone-derived macrophages). 
Increased number of Iba-1 positive cells was detected particularly around the organum 
vasculosum of the lamina terminalis (OVLT, Fig. 3.5B) in the rostral hypothalamus and in 
the median eminence (ME) and arcuate nucleus in the mediobasal hypothalamus (Fig. 
3.5C), but not in the lateral preoptic area (LPO) or the paraventricular nucleus (PVN).  
Since PVN is located adjacent to the 3rd ventricle as is the arcuate nucleus, findings that 
PVN does not exhibit changes in Iba-1 positive cell number, while arcuate nucleus does, 
imply that the distance to the 3rd ventricle is not a contributing factor. Consistent with a 
lack of morphological changes, and lack of changes in the cell number in the arcuate 
nucleus, female mice did not exhibit any differences in Iba-1 cell number in either ME or 
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OVLT hypothalamic area (data not shown). Therefore, solely in male mice, but not in 
female mice, HFD elicits an increase in Iba-1 positive cells in the circumventricular areas 
of the hypothalamus that are known to have a leaky blood-brain barrier.  
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Figure 3.5: Iba-1 positive cells were more abundant in the circumventricular areas of 
the hypothalamus following HFD in male mice, but not in the female. A, Microglia, 
genetically labeled with CX3CR1-GFP, exhibit activated morphology in the arcuate 
nucleus after HFD specifically in male mice, but not in the female. Quantification identified 
that there is no difference in microglia numbers in Ctr males compared to Ctr females, or 
Ctr females compared to HFD females, while male mice on HFD had increased number of 
CX3CR1-GFP cells in the arcuate nucleus compared to the Ctr male mice, indicated with 
an asterisk. B, Increased number of Iba-1 positive cells around the organum vasculosum 
laminae terminalis (OVLT) in DIO male mice fed HFD than Ctr mice, but the same 
numbers in the lateral preoptic area (LPO).  C, Increased Iba-1 positive cell number in the 
median eminence (ME) and arcuate nucleus but not in the paraventricular nucleus (PVN) 
in male mice on HFD. A-C, Bar indicates 100  m.  Difference (*) between Ctr (gray bars) 
and HFD (black bars) were determined by Student’s T-test followed by Tukey’s HSD test. 
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Infiltration of peripheral macrophages to the hypothalamus of obese male mice.  
Given that the increased Iba-1 cell numbers are observed in the areas that contain 
fenestrated capillaries, and that this increase is not dependent on the distance from the 
ventricle, we considered two possibilities, that either microglia sense the metabolic changes 
in the circulation that leads to their activation and proliferation, or that activated monocyte-
derived macrophages enter the hypothalamus from the periphery, since increased adiposity 
leads to macrophage activation [224]. Microglia and macrophages can be distinguished by 
flow cytometry from other CNS resident cells due to the presence of CD11b, and can be 
distinguished from each other by their differential expression of CD45, since microglia are 
CD11b+ CD45low and macrophages are CD11b+ CD45high [226, 232].  Hypothalamus and 
prefrontal cortex were dissected, cells dissociated and subjected to flow analysis, which 
determined that macrophages are present in the hypothalami of obese male mice, but not 
in the cortex (Fig. 3.6A). Consistent with the increase in inflammatory cytokines, 
macrophage recruitment to the hypothalamus is only noted in male mice, and is not 
observed in the female mice on HFD (Fig. 3.6A, B).  
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Figure 3.6: Infiltration of peripheral macrophages in the hypothalamus of the male 
mice on HFD but not female. A, Flow cytometry plot indicating presence of the CD45high 
macrophage population that can be distinguished from the CD45low microglia specifically 
in the hypothalami of HFD male mice, but not in the female. This population is not present 
in the cortex in either male or female mice.  B, Quantification of A. Statistical significance 
(*) between Ctr (gray bars) and HFD (black bars) were determined by Student’s T-test 
followed by Tukey’s posthoc test.  
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To localize resident microglia and recruited monocyte-derived macrophages, we 
generated CX3CR1-GFP and CCR2-RFP double transgenic male mice. CX3CR1 is a 
fractalkine receptor expressed specifically by the microglia in the brain. CCR2 is a 
chemokine receptor involved in monocyte chemotaxis and infiltration; thus, the presence 
of RFP expression under CCR2-promoter control would indicate infiltrating activated 
macrophages.  These mice were placed on a Ctr and HFD.  In the Ctr, only green-labeled 
microglia positive for CX3CR1 are present in the arcuate nucleus of the mediobasal 
hypothalamus (Fig. 3.7, coronal section with 3rd ventricle on the right side of the image), 
while in the HFD, RFP-labeled infiltrating macrophages are localized to the brain 
parenchyma in addition to the GFP-labeled resident microglia. Collectively, these results 
indicate that peripheral macrophage recruitment to the hypothalamic parenchyma 
following HFD only occurs in male mice.  
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Figure 3.7: CCR2-positive macrophages localize to the parenchyma of the arcuate 
nucleus. Doubly fluorescent mice, where activated macrophages are genetically labeled 
red with CCR2-RFP and resident microglia are labeled green with CX3CR1-GFP, were 
placed on the control and HFD. Arcuate nuclei of mice on control diet contain only green 
fluorescence, while arcuate nuclei of mice on HFD contain green fluorescence of resident 
microglia, and red fluorescence indicating infiltration of peripheral macrophages. 
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Discussion 
 There are also profound sex differences in the immune system [233], metabolic rate 
and oxidative phosphorylation [234], fat deposition [204] and adipocyte number and size 
[235], all of which may or may not be dependent on sex steroids, gonadally or locally 
produced. Our results indicate that sex differences may stem from differences in 
inflammation or alternate fat deposition, both of which may be interdependent.  Females 
have higher prevalence of autoimmune diseases, but exhibit lower rates of infections and 
fewer chronic inflammatory diseases [233]. Resistance to chronic inflammatory diseases 
may protect them from obesity-mediated chronic inflammation. Female mice in our study 
had elevated levels of anti-inflammatory IL-10 in the hypothalamus, which may provide 
them protection from neuroinflammation. On the other hand, we and others also 
determined differences in fat deposition [203, 236]. Our results agree that males have larger 
visceral fat depots, or gonadal fat pad, with observation in other models and humans, and 
that premenopausal females preferentially deposit fat into the subcutaneous depot [202]. 
Difference in fat deposition may also be sex steroid dependent [237, 238]; and likely 
provides protection for females, since subcutaneous fat is less adversely correlated with 
negative effects of obesity than visceral fat. Variances in fat depots, not only absolute 
adiposity, may impact obesity induced inflammation, since visceral fat, more abundant in 
males, contains more infiltrating macrophages and higher expression of inflammatory 
cytokines [122, 239]. 
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 Previous studies analyzing effects of obesity identified that neuroinflammation is 
specific for the hypothalamus and determined that microglia changes morphology 
specifically in the arcuate nucleus [228, 231]. In agreement, our studies also failed to detect 
microglia morphology changes in the cortex and detected them specifically in the 
hypothalami. Sex differences in microglia activation in response to obesity have also been 
reported previously [240]. Our studies similarly detected morphology changes specifically 
in the male mice. To assess the regional specificity, we further analyzed other areas besides 
arcuate nucleus and determined that microglia morphology changes around other 
circumventricular areas with fenestrated capillaries, such as OVLT. We considered two 
possibilities, that either microglia sense metabolic changes in the circulation via fenestrated 
capillaries in circumventricular areas or that increased numbers indicate that peripheral 
cells which label with anti-Iba-1 cross into the brain parenchyma specifically in these areas 
due to the lack of the blood-brain barrier. That prompted us to investigate potential 
peripheral cells and determine that macrophages enter the hypothalamus. 
 Macrophages are functionally dominant cells in obesity-induced chronic 
inflammation [241]. With increased adiposity, proportion of macrophages in adipose tissue 
increases from 10% to 50%, and they change from less inflammatory M2 phenotype to 
pro-inflammatory M1 phenotype [122, 224, 242, 243]. Elevated macrophage infiltration 
and cytokines secretion is more highly correlated with visceral adiposity [202]. 
Inflammatory cytokines secreted by the adipose tissue macrophages contribute to the 
increase in TNFa and IL-6 in the circulation and chronic inflammation in obese mice and 
people [131]. We determined that activated macrophages infiltrate the hypothalamus in the 
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DIO male mice. Macrophages are recruited to adipose tissue in part via CCR2 interaction 
with CCL2 that is upregulated in obesity [244]. CCR2 is involved in the macrophage 
recruitment to the liver in obese mice, which contributes to insulin resistance [245]. Thus, 
macrophages activated by increased adiposity infiltrate parenchyma of other tissues. We 
demonstrated that macrophages recruited to the hypothalamus of obese mice likewise 
express CCR2.  Macrophage switch to pro-inflammatory phenotype with increasing 
obesity also entails a decrease in the anti-inflammatory IL-10 expression in obese adipose 
tissue [223, 246]. Thus, protective role of IL-10 in adipose tissue in DIO has been 
postulated previously but sex differences were not examined [247, 248]. We determined 
that female mice have higher basal levels of IL-10 in the hypothalamus and that obesity 
exacerbates sex differences since IL-10 is further decreased in obese males in the 
hypothalamus as well.  In the brain, IL-10 is expressed by glial cells [249] and has a 
protective function [250]. We postulate that females, due to the need to handle larger 
weight changes during pregnancy and lactation, exhibit higher levels of protective anti-
inflammatory IL-10 and that increased levels of anti-inflammatory cytokines in female may 
afford them protection from obesity-induced inflammation.  
 Given that POMC and NPY neurons are located in the arcuate nucleus, in light of 
our results, their synapses may be also eliminated by macrophages or activated microglia. 
Microglia, brain resident immune cells, are involved in synapse prunning and synapse 
maturation during development [251] and in the regulation synaptic transmission and 
activity-dependent structural remodeling in adults [252]. Peripheral, monocyte-derived 
macrophages, however, enter the brain in pathological conditions phagocytosing damaged 
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cells and engulfing synapses [253]; [254]. We demonstrated that male mice, but not 
females, on HFD exhibit macrophage infiltration to the hypothalamus in addition to the 
microglia activation, however future studies will identify which of these cells is activated 
first.  Our studies also demonstrate that synaptic proteins are decreased in the hypothalami 
of obese male mice. Furthermore, we report sex specific changes in neuroinflammation 
and fat deposition that may explain sex differences in adverse effects of obesity. Future 
studies will further elucidate sex differences in adiposity and obesity-induced 
inflammation. Here in we examine immune parameters to identify sex-specific effects of 
obesity on hypothalamic function.  
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Abstract 
The mechanisms whereby neuroinflammation negatively affects neuronal function 
in the hypothalamus are not clear. Our previous study determined that obesity-mediated 
chronic inflammation elicits sex-specific impairment in reproductive function via 
reduction in spine density in GnRH neurons. Neuroinflammation and subsequent decrease 
in GnRH neuron spine density was specific for male mice, while protection in females was 
independent of ovarian estrogens. To examine if neuroinflammation-induced cytokines can 
directly regulate GnRH gene expression, herein we examined signaling pathways and 
mechanisms in males in vivo and in GnRH-expressing cell line, GT1-7. GnRH neurons 
express cytokine receptors, and chronic or acute neuroinflammation represses GnRH gene 
expression in vivo. Leukemia inhibitory factor (LIF) in particular represses GnRH 
expression in GT1-7 cells, while other cytokines do not. STAT3 and MAPK pathways are 
activated following LIF treatment, but only MAPK pathway, specifically p38α, is sufficient 
to repress GnRH gene. LIF induces cFOS that represses GnRH gene via the -1793 site in 
the enhancer region. In vivo, following high fat diet, cFOS is induced in GnRH neurons 
and neurons juxtaposed to the leaky blood brain barrier of the organum vasculosum of the 
lamina terminalis, but not in the neurons further away. Our results indicate that the increase 
in LIF due to neuroinflammation induces cFOS and represses GnRH gene. Therefore, in 
addition to synaptic changes in GnRH neurons, neuroinflammatory cytokines directly 
regulate gene expression and reproductive function, and the specificity for neuronal targets 
may stem from the proximity to the fenestrated capillaries.  
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Introduction 
Gonadotropin releasing-hormone (GnRH) is the final brain output for the regulation 
of reproduction. GnRH neurons, which are scattered in the hypothalamus, synthesize and 
secrete GnRH, which acts on the anterior pituitary to stimulate the synthesis and secretion 
of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from gonadotrope 
cells [2, 3]. LH and FSH act on the gonads to promote steroidogenesis and gametogenesis. 
GnRH neuronal processes, named “dendrons”, by Herbison group [201], form an 
interwoven network that receives direct synaptic and neuropeptide input from upstream 
regulatory neurons, most notably kisspeptin [41, 177]. This GnRH network integrates other 
signals that impinge on reproduction, such as stress [255, 256], endocrine disruptors [181], 
circadian rhythms [257, 258], metabolism [169, 171], and acute inflammation during 
infection [153, 259, 260].  
Previous studies have implicated acute inflammation, elicited with an injection of 
lipopolysaccharide (LPS), in the impairment of reproductive function [153, 211, 261]. LPS 
challenged rodents exhibited reduced levels of LH and GnRH mRNA, diminished release 
of LH and GnRH, and increased levels of pro-inflammatory cytokines, such as tumor 
necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in the circulation [153, 154, 262, 
263]. Centrally administered cytokines also provoked reduced LH and GnRH levels, but 
the mechanism whereby these cytokines mediate their effects is unknown [155, 156, 211, 
261, 264]. More recently, our group determined that low-grade, chronic inflammation 
caused by high fat diet (HFD)-induced obesity may also directly affect GnRH neurons, 
resulting in reduced levels of LH in circulation and diminished GnRH mRNA levels in the 
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hypothalamus, specifically in male mice [20]. We, and others, have reported that diet-
induced obese mice and people exhibited increased levels of pro-inflammatory cytokines, 
TNF-α, IL-1β, and IL-6, in circulation [20, 131] and in the hypothalamus, at the mRNA 
level and protein level [20, 265]. Additionally, we also identified that leukemia inhibitory 
factor (LIF), a member of the IL-6 family, is increased in the circulation and locally 
produced in male mice hypothalami in obesity [20]. Interestingly, LIF is increased in a sex-
specific manner only in males that exhibit reduction in GnRH mRNA and gonadotropin 
hormones, but not in females that lack changes in GnRH or gonadotropin hormones. IL-6, 
a prototypical member of the family, on the other hand, is increased in both sexes. Our 
previous study postulated that impairment of GnRH neurons stems from reduction in spine 
density and consequently the connectivity of the GnRH network [20]. However, GnRH 
neurons express several cytokine receptors [157] and inflammation-induced cytokines may 
directly regulate intracellular signaling pathways in the GnRH neurons. We are interested 
in delineating the mechanisms by which inflammatory cytokines influence GnRH gene 
expression to provide insight into the etiology of neuroinflammation-induced impairment 
of reproductive function. TNFa, IL-1b, and IL-6 are key players in the regulation of 
immune response and inflammatory processes during infection [266]. In the central 
nervous system, TNFa and IL-1b regulate synaptic plasticity, neurodegeneration, learning 
and memory [267-270]. During infection, both of these cytokines mediate the physiological 
and behavioral responses in sickness such as, inducing fever, inhibiting food intake, 
causing nausea and fatigue [133-135]. TNF-a and IL-1b mediate their effects through 
activation of downstream signaling molecules: nuclear factor-kappa B (NFk-B), Janus 
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kinase and signal transducers and activators of transcription pathway (JAK-STAT) and 
mitogen activated protein kinases (MAPK) [136-138]. Similarly, IL-6 is produced in 
response to infection and stress, and in turn stimulates various cell populations, also 
through the JAK-STAT and MAPK pathways [271]. In the brain, IL-6 is involved in 
degenerative responses. [272, 273]. However, IL-6 is also induced following TNFa or IL-
1b treatment and is involved in the negative feedback that ultimately contributes to the 
dampening of the immune response and activating tissue repair [274].  
LIF is a member of IL-6 family that is induced during inflammatory response [144]. 
However, its functions are not limited to inflammation: LIF has been demonstrated to play 
a crucial, non-redundant role in embryo implantation in both mice and humans [145-147]. 
LIF also maintains stem cells and regulates differentiation of germ cells [148, 149]. In the 
brain, LIF regulates neuronal function and neuronal response to injury [150-152]. With 
respect to GnRH neurons, LIF has been shown to regulate the migration of GN11 immature 
GnRH neuron cell line and regulate the release of GnRH in GT1-7 cells [225, 275, 276]. 
LIF binds its specific receptor, which, similarly to the other members of the IL-6 family, 
recruits and signals through the GP130 signals transducer, activating JAK-STAT pathway 
[146]. Signaling pathways involved in the regulation of GnRH gene transcription by any 
of these cytokines have not been elucidated.   
GnRH neurons in the rodent hypothalamus are located in the preoptic area 
surrounding organum vasculosum laminae terminalis (OVLT) and send long processes to 
the median eminence (ME) where secretion occurs from the terminals. Both OVLT and 
ME are areas that contain fenestrated capillaries and a leaky blood-brain barrier [175]. A 
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subpopulation of GnRH neurons extends their processes into the OVLT and across the 
blood-brain barrier, where they may be able to directly respond to circulating molecules, 
including cytokines [277]. OVLT and surrounding thermoregulatory neurons are involved 
in changes in body temperature and inducing fever in response to systemic inflammation. 
Pyrogenic, pro-inflammatory cytokines, TNFa, IL-1b and IL-6, produced locally in the 
hypothalamus, or from the circulation via fenestrated capillaries in the OVLT, stimulate 
thermoregulatory neurons to increase the body temperature [278-281]. In addition, we 
postulate that these cytokines directly regulate GnRH neurons in the proximity to OVLT. 
About 800-1200 GnRH neurons are scattered throughout the forebrain of a mouse 
[282]. This poses a challenge for molecular studies of GnRH neurons in vivo.  GT1-7 cells 
are the only model of mature, terminally differentiated, GnRH-producing neurons, and 
have been used to identify regulatory elements and transcription factors important for 
GnRH transcription [283, 284]. GT1-7 cells allow for the investigation of molecular 
mechanisms and direct effects on GnRH gene expression without confounding variables 
that may be present in in vivo studies. Here, we combine in vivo mouse studies and 
investigate the direct effects of cytokines on GnRH gene expression in GT1-7 cells. Our 
results delineate the molecular mechanisms and signaling pathways that LIF activates and 
strongly suggest that LIF directly affects GnRH neurons to regulate GnRH gene expression 
in infection or obesity induced inflammation of the hypothalamus.  
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Materials and Methods  
Animals 
 C57BL/6J mice were maintained under a 12-h light, 12-h dark cycle and received 
food and water ad libitum. All experiments were performed with approval from the 
University of California (Riverside, CA) Animal Care and Use Committee and in 
accordance with the National Institutes of Health Animal care and Use Guidelines. 
C57BL/6J male mice were placed on either a high fat diet (HFD, D12492, 60% kcal from 
fat; 5.21 kcal/g;  protein 20% kcal; fat 60% kcal (lard 0.32 g/g diet, soybean oil 0.03 g/g); 
carbohydrate 20% kcal;  Research Diet, New Brunswick, NJ) or control diet (CTR, 
D12450J, 10% kcal from fat; matching sucrose levels to HFD; 3.82 kcal/g; protein 20% 
kcal; fat 10% kcal (lard 0.02 g/g diet, soybean oil 0.025 g/g); carbohydrate 70% kcal; 
Research Diet, New Brunswick, NJ) from weaning age for 12 weeks. Mice treated with 
vehicle or LPS were fed standard food pellets (STD, 5053, 4.07 kcal/g; protein 24% kcal; 
fat 13%; carbohydrates 63%; St. Louis, MO) from weaning. Lipopolysaccharide (LPS, 2.5 
mg/kg body weight) from Escherichia coli (catalog # L4391, Sigma, USA) was 
administered by intraperitoneal injection. Mice were sacrificed 24 h post LPS treatment in 
parallel with the corresponding control groups. At least 10 animals/diet or treatment were 
analyzed unless otherwise indicated, and differences from corresponding controls were 
compared by Student’s t test. GnRH-GFP mice were kindly provided by Dr. Suzanne 
Moenter [192] to facilitate investigation of fluorescently labeled GnRH neurons. 
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Histological Analysis and Immunohistochemistry  
For brain collection, animals were perfused with ice cold phosphate buffer saline 
(PBS) solution followed by 4% paraformaldehyde solution. Brains were post-fixed in 4% 
paraformaldehyde 2 h at room temperature and cryopreserved in 30% sucrose/PBS solution 
for 3 days at 4°C before freezing in OTC. Frozen brains from GnRH-GFP mice were 
sectioned to 30 µm sections and stained for GFP to visualize GnRH neurons and for GP130 
or cFOS. Slides were blocked with 20% goat serum and incubated with primary antibodies 
against GFP (1:5000 raised in chicken, Table 1) at 4°C for 48 h. After PBS washes, slides 
were incubated with FITC/Alexa 488 goat anti-chicken IgG (1:300, Molecular Probes, 
Eugene, OR) for 1 h. Slides were then incubated with primary antibodies against GP130 
(1:500, MAB4681, R&D Systems, Minneapolis, MN) or cFOS (1:300, SC-52, Santa Cruz 
Biotechnology, Inc. Dallas, TX) for 48 h at 4°C followed by Alexa 594 goat-anti-rat IgG 
(1:300, Molecular Probes, Eugene, OR)  or biotinylated goat anti-rabbit IgG (1:300; Vector 
Laboratories, USA) and Cy5-streptavidin (1:300, 434316, Life Tech. Corp. Eugene, OR) 
for 1 h each at room temperature, respectively. Sections were mounted and slides covered 
using VectaSheild mounting media with DAPI (H-1500, Vector Laboratories, USA). 
Secondary antibody-only controls were performed to determine antibody specificity. 
Images were obtained using a Leica microscope system.  
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To quantify the number of cFOS expressing GnRH neurons, coronal sections of the 
preoptic area in the hypothalamus of GnRH-GFP mice were stained for GFP (green) and 
cFOS (red). Three hundred GnRH-GFP neurons from each of the four male mice from 
control and HFD group were counted for the co-labeling with cFOS and results represented 
as a percent of total GFP labeled neurons. To assess expression of cFOS in other cells, two 
100 µm x 100 µm areas, one area proximal to the organum vasculosum of the lamina 
terminalis (OVLT) and one more dorsal, in the same section were counted to quantify the 
number of cFOS expressing cells, where DAPI staining was used to identify cell nuclei. 
Statistical differences (p < 0.05) were determined by Student’s T-test. 
 
qPCR Analysis 
Hypothalami were dissected, total RNA extracted using MicroRNA kit from 
Ambion and reverse transcribed using Superscript III (Invitrogen, CA). qPCR was 
performed using an iQ SYBR Green supermix and an IQ5 real-time PCR machine (Bio-
Rad Laboratories, Hercules, CA), with primers listed in Table 2, under the following 
conditions: 95 ºC for 15 min, followed by 40 cycles at 95 ºC for 20 s, 56 ºC for 30 s, and 
72 ºC for 30 s. The amount of the gene of interest was calculated by comparing the 
threshold cycle obtained for each sample with the standard curve generated in the same run 
and normalized to the beta-2-microglobulin (B2M) housekeeping gene in the same sample 
using DDCt method. Replicates were averaged. After each run, a melting curve analysis was 
performed to confirm that a single amplicon was generated in each reaction.  
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Statistical differences (p < 0.05) in expression were determined by Student’s T-test using 
JMP software (SAS Institute; Cary, North Carolina). 
 
Cell Culture  
GT1-7 cells, kindly provided by Pamela Mellon (University of California, La Jolla, CA), 
were cultured in DMEM (Cellgro, Mediatech, Inc., Herndon, VA) with 10% FBS. 
Leukemia Inhibitory Factor (LIF, 34-8521; eBioscience, USA) and interleukin 6 (IL-6, 
216-16, PeproTech, Rocky Hill, NJ) were reconstituted in PBS containing 0.1% BSA and 
stored in aliquots at -80°C until use. RNA was isolated with TRIzol (Life Tech. Carlsbad, 
CA) and RT-PCR performed as previously described [285, 286].  
 
Western Blot Analysis            
 Whole cell lysates were obtained after treatment with 10 ng/mL LIF or vehicle for 
times indicated, using lysis buffer (20 mM Tris-HCl, pH 7.4, 140 mM NaCl, 0.5% Nonidet 
P-40, 0.5 mM EDTA) with 1% protease inhibitor cocktail (P8340, Sigma, USA) and 1 mM 
PMSF. Protein content was determined using Bradford reagent (Bio-Rad Laboratories Inc. 
USA). An equal amount of protein from each sample was resolved on a 10% SDS-PAGE 
and electrotransferred to a nitrocellulose membrane.  
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Membranes were blocked in TBST (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween-
20) with 10% non-fat milk for 2 h room temperature and incubated overnight with specific 
antibodies for p-STAT3 (1:1000; 9134, Cell Signaling, Danvers, MA), STAT3 (1:1000, 
9139, Cell Signaling, Danvers, MA), p-p38 (1:1000, 9211, Cell Signaling Danvers, MA), 
p38 (1:1000, 9212, Cell Signaling Danvers, MA), p-ERK1/2 (1:1000, 9101, Cell Signaling, 
Danvers, MA), ERK1/2 (1:1000, 9102, Cell Signaling, Danvers, MA), p-JNK (1:1000, 
9255, Cell Signaling, Danvers, MA), JNK (1:1000, 9252, Cell Signaling, Danvers, MA), 
OCT-1 (1:500, ab66132, Abcam, Cambridge, UK), cFOS (1:1000, SC-52, Santa Cruz 
Biotechnology, Inc. Dallas, TX), and b-tubulin (1:1000, SC-9104, Santa Cruz 
Biotechnology, Inc., Dallas, TX). The bands were visualized with horseradish peroxidase 
(HRP)-linked secondary antibodies and enhanced chemiluminescence reagent (ECL; 
Amersham Bioscience), as described by manufacturer. Blots were exposed to 
autoradiography film (Bioexpress, USA). Each experiment was performed 3 times and 
representative images are presented. 
 
Transfections 
Cells were plated into 12-well plates and transfected using Fugene 6 reagent (Roche 
Applied Science), as described previously [286-289]. Wells were transfected with 500 ng 
of reporter plasmid, 100 ng of b-galactosidase reporter plasmid driven by the Herpesvirus 
thymidine kinase promoter, as an internal control for the efficiency of the transfection, and 
200 ng of expression vectors or empty vector control, as indicated in the figure legends.  
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24 h after transfection, cells were switched to serum-free media (DMEM with 0.1% BSA) 
and treated with either 10 ng/mL LIF, 20 ng/mL IL-6 or vehicle for 24 h. Following 
treatment, cells were lysed in 0.1 M potassium phosphate buffer, pH 7.8, with 0.2% Triton 
X-100. Luciferase activity in the lysates was measured with a Veritas Microplate 
luminometer (Turner Biosystems, Sunnyvale, CA) after injection with 100 µL of luciferase 
assay buffer (100mM Tris-HCl, pH 7.8, 15 mM MgSO4, 10 mM ATP, and 65 µM 
luciferin). b-galactosidase activity was measured using the Tropix Galacto-light b-
galactosidase assay (Applied Biosystems, Foster City, CA). All experiments were 
performed three independent times and in triplicates within each experiment. Luciferase 
values were normalized to b-galactosidase values for each sample. Results are presented 
as an average of three experiments. Statistical significance, p < 0.05, was determined with 
ANOVA followed by Tukey’s post hoc test using JMP software (SAS Institute; Cary, 
North Carolina). 
 
Plasmids 
The reporter plasmids were kindly provided by Pamela Mellon (University of 
California, La Jolla, CA). The -5 kb rat GnRH (-4984 to +22 relative to the transcription 
start site); GnRH E/P, which contains GnRH-E1 (-1863 to -1571)/GnRH-P (-173 to +112); 
and GnRH-P (-173 to +112) luciferase reporters have previously been described [78, 290-
292]. Luciferase reporter plasmids containing mutations of AP1 binding site in GnRH 
enhancer and GnRH promoter, and reporter plasmids with RSV promoter fused to GnRH 
enhancer (GnRHe/RSVp), have also been previously described [78, 290-292]. The 
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expression vectors for wild type (WT) STAT3 (Stat3 Flag pRC/CMV, #8707, Addgene, 
Cambridge), dominant negative (DN) STAT3 (Stat3 Y705F Flag pRC/CMV, #8704, 
Addgene, Cambridge), constitutively active (CA) STAT3 (Stat3-C Flag pRC/CMV, 
#8722, Addgene, Cambridge), and luciferase reporter containing STAT3 response element 
(4xM67 pTATA TK-Luc, #8688, Addgene, Cambridge, MA) were purchased from 
Addgene and have previously been described [293].  Expression vectors for constitutively 
active RAS, MEK1, MEK2, MKK4, MKK7, MKK3, MKK6, and constitutively active 
isoforms of p38 (p38a, p38b, p38l, p38d) were a gift from Peiqing Sun (The Scripps 
Research Institute, La Jolla, CA) [294]. Expression vector for cFOS has been previously 
described [285, 295-297]. 
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Table 4.1 Antibodies used for western and immunohistochemistry 
Antibody Species Dilution Provider, cat #  
GFP chicken  1:5000 Abcam, ab1397 
GP130 rat 1:300 R&D Systems, MAB4681; clone#125623 
STAT3 mouse 1:1000 Cell Signaling, 9139 
p-STAT3 rabbit 1:1000 Cell Signaling, 9145 
p38 rabbit 1:1000 Cell Signaling, 9212 
p-p38 rabbit 1:1000 Cell Signaling, 9211 
ERK 1/2 rabbit 1:1000 Cell Signaling, 9102 
p-ERK 1/2 rabbit 1:1000 Cell Signaling, 9101 
JNK rabbit 1:1000 Cell Signaling, 9252 
p-JNK mouse 1:1000 Cell Signaling, 9255 
OCT-1 rabbit 1:500 Abcam, ab66132 
cFOS rabbit 1:300, 1:1000 Santa Cruz Biotechnology, sc-52 
b-tubulin rabbit  1:1000 Santa Cruz Biotechnology, sc-9104 
 
Table 4.2 Primers used for qPCR 
Primers Forward Reverse 
Gnrh 
(GnRH) CTACTGCTGACTGTGTGTTTG CATCTTCTTCTGCCTGGCTTC 
Il6 (IL-6) TTCTCTGGGAAATCGTGGAAAT 
TCCAGTTTGGTAGCATCCATC
A 
Tnfa (TNF-
a) 
ATGTCTCAGCCTCTTCTCATTC
C 
GCTTGTCACTCGAATTTTGAG
AA 
Il1b (IL1b) GCAACTGTTCCTGAACTCAACTG 
CACAGCCACAATGAGTGATA
CTG 
Lif (LIF) ATGTGCGCCTAACATGACAG TATGCGACCATCCGATACAG 
B2m (beta-
2-
microglobul
in 
TGACCGGCCTGTATGCTATCCA CAGTGTGAGCCAGGATATAGAAAGAC 
LIFR TCAGTTTCAGCCAGGAGTAA GCAATAATCAATCCCACAGA 
IL6R AAGCAGCAGGCAATGTTACC CATAAATAGTCCCCAGTGTCG 
GP130 GCGTACACAGATGAAGGTGGGAAAGA 
GCTGACTGCAGTTCTGCTTG
A 
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Results 
Inflammation in the hypothalamus induces inflammatory cytokines and represses 
GnRH.  
Inflammation, either acute, caused by an injection of lipopolysaccharide (LPS), or 
chronic, elicited by high fat diet (HFD), negatively affects hypothalamic neurons and in 
particular, reproductive function [155, 163]. We and others postulated this impairment is 
due to the repression of the GnRH gene, which is the final brain signal in the control of 
reproduction. Inflammatory cytokines have previously been proposed to negatively 
regulate GnRH neurons [211, 262, 298].  We initiated our studies with an analysis of 
cytokine mRNA levels in the hypothalami of C57BL/6 male mice, induced by LPS 
injection, a bacterial endotoxin known to elicit an inflammatory response. Our studies 
revealed that tumor necrosis factor alpha (TNF-a, Tnf) mRNA was induced 22-fold, 
interleukin 1 beta (IL-1b, Il1b) was induced 7-fold, IL-6 (Il6) 1.6-fold, and leukemia 
inhibitory factor (LIF, Lif) 2.2-fold after LPS injection (Fig. 4.1A). Gnrh mRNA level in 
mice treated with LPS was reduced by 72% (Fig.4.1A).  
Obesity is considered a state of chronic inflammation as opposed to acute 
inflammation elicited by LPS injection [20, 131, 222]. Thus, we exposed male C57BL/6J 
mice to HFD or to control diet (CTR) for 12 weeks. Diet-induced obesity induced TNF-a 
1.6-fold and IL-1b 1.7-fold, although due to variability, it did not reach significance (Fig. 
4.1B). IL-6 was significantly induced 3.1-fold and LIF 1.6-fold, compared to mice fed CTR 
diet (Fig. 4.1B).  
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Further analysis revealed significantly reduced Gnrh mRNA levels by 46%, compared to 
the controls (Fig. 4.1B). Thus, increase in locally produced cytokines, acute and chronic, 
correlates with repression of GnRH mRNA expression.  
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Figure 4.1: GnRH expression is repressed when cytokine levels are increased.  A, 
Hypothalami from male mice 24 hours after injection with either vehicle control (CTR, 
white bars) or lipopolysaccharide (LPS, gray bars). B, Hypothalami from male mice 
following 12-week feeding with control (CTR, white bars) or high fat diet (HFD, black 
bars). Cytokine and GnRH (Gnrh1) expression was assayed with RT-qPCR. TNF-a, (Tnf) 
tumor necrosis factor alpha; IL-1b, (Il1b) interleukin 1 beta; IL-6, (Il6) interleukin 6; LIF, 
(Lif) leukemia inhibitory factor. * indicates significant difference (p<0.05) determined with 
t-test. 
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LIF represses GnRH  
We then determined whether these locally produced, inflammatory cytokines can 
regulate GnRH gene expression directly. Due to the scarcity and scattered location of 
GnRH neurons in mice, in vivo analysis of molecular mechanisms whereby cytokines 
regulate GnRH gene is not possible. To analyze direct effects of cytokines on gene 
expression we employed GT1-7 cells that are an established Gnrh expressing and GnRH 
secreting cell model [283]. We expressed GnRH 5 kb luciferase reporter (5 kb GnRH luc) 
in GT1-7 cells and treated with inflammatory cytokines. LIF repressed GnRH reporter 
expression by 45.7% compared to CTR (Fig. 4.2A, black bar), similar to what was observed 
in vivo with LPS injection and HFD. TNF-a, IL-1b and IL-6 had no effect on GnRH 
expression. To further analyze the effect of LIF treatment on GnRH gene, RNA was 
isolated from GT1-7 cells treated with either vehicle or LIF, reverse transcribed and 
quantitative RT-PCR performed. LIF treatment reduced endogenous GnRH mRNA levels 
by 39.1% (Fig. 4.2B).  Taken together, these results indicate that LIF represses Gnrh gene.  
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Figure 4.2: GnRH expression is suppressed by LIF. A, GT1-7 cells transiently 
transfected with 5 kb GnRH-reporter (5 kb GnRH Luc) treated with vehicle (CTR, white 
bar), or TNF-a, IL-1b, IL-6, LIF, for 24 hours. Luciferase values were normalized to b-
galactosidase values for each sample. Results are presented as an average of three 
experiments performed in triplicate. Statistical significance (p < 0.05) was determined with 
ANOVA followed by Tukey’s post hoc test, and indicated with *. B, RT-qPCR using total 
RNA from GT1-7 cells treated with LIF, 10 ng/mL for 24h, demonstrates repression of 
endogenous GnRH mRNA (Gnrh1). * indicates significant difference determined with 
t-test (p<0.05). 
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Since LIF and IL-6 belong to the same cytokine family, it was surprising that LIF 
repressed GnRH while IL-6 did not. These two cytokines share GP130 signaling receptor, 
but each has a specific receptor for ligand binding. We analyzed the expression of their 
specific receptors on GnRH neurons to explain why IL-6 had no effect on GnRH gene 
expression. We first demonstrated the expression of GP130 cytokine signaling receptor 
(red) on GnRH neurons (green) in vivo using immunocytochemistry of hypothalamic slices 
(Fig. 4.3A). This suggests that LIF and IL-6 cytokines can act on GnRH neurons in the 
mouse.  Since antibodies for specific LIF receptor (LIFR) and IL-6 receptor (IL-6R) were 
not effective in immunohistochemistry, we analyzed mRNA expression of these receptors 
using RNA isolated from GT1-7 cells. Products of expected size for GP130 (177 bp), and  
LIFR (452 bp), were present in both GT1-7 cells and spleen, which served as a positive 
control, but absent in negative control samples lacking reverse transcriptase (Fig. 4.3B). 
IL-6R expression (156 bp) was absent in GT1-7 cells, but present in spleen (Fig, 4.3B). 
qPCR analysis reveals that the expression of IL-6R is limited in GT1-7 cells, compared to 
the expression of GP130 and LIFR, while expression levels of these receptors was similar 
in spleen (Fig. 4.3C). These results indicate that LIF can directly bind GnRH neurons and 
affect GnRH gene expression. 
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Figure 4.3: GP130 is expressed in GnRH neurons in vivo and in GT1-7 cells. A, 
Immunohistochemistry of GnRH neurons genetically labeled with GFP (green), stained for 
GP130 receptor (red). Bar indicates 25µm. White arrows indicate GnRH neurons that 
express GP130, while arrowheads indicate GP130 staining in non-GnRH cells. B, RT-PCR 
demonstrates expression of GP130 (177 bp) and LIFR (452 bp), but not IL-6R (156 bp) in 
GT1-7 cells (RT+), while all three receptors are expressed in the spleen (S). RT-, GT1-7 
cells mRNA used without reverse transcriptase serves as negative controls; L, size ladder. 
C, RT-qPCR demonstrates relative expression of GP130, LIFR, IL-6R in GT1-7 cells and 
the spleen.  
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LIF functions via GnRH enhancer to repress GnRH gene 
The 5 kb GnRH reporter contained two upstream regulatory elements: the 300 bp 
enhancer (−1863 to −1571) and the evolutionarily conserved promoter (−173 to +1), that 
confer neuron-specific activation of the GnRH, in culture and in vivo [63, 290, 299]. To 
map the elements necessary for LIF mediated repression of GnRH expression, GT1-7 cells 
were transiently transfected with a luciferase reporter containing the 5 kb regulatory region 
upstream of the GnRH transcription start site (5 kb GnRH), a reporter containing the 
enhancer and promoter without intervening sequences (GnRH E/P) or a reporter containing 
the promoter (GnRH P). LIF repressed luciferase activity of the 5 kb GnRH reporter and 
of the reporter containing the enhancer and promoter, GnRH E/P luc, by 45.7% and 42.6% 
respectively (Fig. 4.4A and 4.4B). Luciferase activity of the reporter containing only the 
promoter, GnRH P luc, did not change in response to LIF (Fig. 4.4C). Next, to examine if 
the enhancer is sufficient for repression, the reporter containing enhancer fused to 
heterologous RSV promoter was examined (GnRH E/RSVp luc). LIF treatment 
significantly repressed GnRH E/RSVp luc reporter by 45.2% (Fig. 4.4D). Given that GnRH 
E/P and GnRH E/RSVp reporters were repressed to a similar degree by LIF as the full 
length 5 kb GnRH reporter, these results indicate that the enhancer is sufficient and 
necessary for repression by LIF.  
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Figure 4.4: LIF represses GnRH gene expression through the enhancer region. A, 5 
kb GnRH reporter containing 5 kb of the GnRH gene regulatory sequence from the 
transcriptional start site; B, reporter containing GnRH enhancer (E, -1863/-1571) and 
promoter (P, −173/+1); C, reporter containing GnRH promoter -173/+1 (P) and D, reporter 
containing GnRH enhancer (E, -1863/-1571) linked to the heterologous RSV (Raus 
Sarcoma Virus) promoter (GnRH E/RSVp luc); were transfected in GT1-7 cells and cell 
treated with LIF for 24h. Results demonstrate sufficiency of the enhancer for GnRH 
repression by LIF. Statistical significance, p < 0.05, indicated with *, was determined with 
a t-test. 
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STAT3 is not necessary for GnRH repression by LIF 
LIF signals through GP130 to activate the signal transducer and activator of 
transcription (STAT) pathway. To analyze signaling pathways activated by LIF, cells were 
treated with LIF and western blots performed using whole cell lysate. LIF treatment 
resulted in increased levels of STAT3 phosphorylation (Fig. 4.5A). To determine whether 
STAT3 is sufficient to repress GnRH gene expression, GT1-7 cells were co-transfected 
with a constitutively active STAT3 mutant (CA STAT3) and STAT binding region (SBR), 
a reporter containing 6 copies of the STAT3 response element that serves as a positive 
control; or with GnRH E/P reporter. CA STAT3 overexpression induced STAT3-SBR to 
the similar level as induction by LIF. LIF treatment together with CA STAT3 
overexpression did not further increase induction over CA STAT3 alone, indicating that 
CA STAT3 maximally induces SBR reporter.  On the other hand, CA STAT3 
overexpression did not affect the expression of the GnRH E/P reporter or its repression by 
LIF (Fig. 4.5B). We then analyzed necessity of STAT3 by co-transfecting dominant 
negative mutant STAT3 (DN STAT3) with SBR or with GnRH E/P. While transfection 
with DN STAT3 inhibited LIF induction of SBR positive control, DN STAT3 did not 
prevent repression of GnRH E/P by LIF (Fig. 4.5C). Taken together, these results 
demonstrate that STAT3 is not necessary for GnRH repression by LIF.  
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Figure 4.5: STAT3 is not sufficient or necessary for GnRH repression by LIF. A, 
Analysis of STAT3 phosphorylation by western blot of GT1-7 cell lysates after 10 ng/mL 
LIF treatment, for 10, 30 and 120 minutes. B, Co-transfection of a reporter containing 6 
copies of the STAT3 response element (SBR) or GnRH E/P with a constitutively active 
(CA) STAT3 demonstrates that CA-STAT3 is sufficient to induce SBR, but not GnRH 
E/P. C, Co-transfection of a dominant negative (DN) STAT3 inhibits LIF induction of 
SBR-luciferase, but does not prevent LIF repression of the GnRH E/P reporter. Statistical 
significance (*, p < 0.05) was determined with ANOVA followed by Tukey’s post hoc test. 
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LIF activates p38 to repress GnRH 
LIF signaling has been shown to activate the mitogen activated protein kinase 
(MAPK) pathway, which include extracellular signal-regulated protein kinases (ERK1/2), 
p38, and the c-Jun N-terminal kinases (JNK) in a variety of other cells, including mouse 
embryonic stem cells, 3T3-L1, and AtT20 pituitary corticotrope cells [300, 301]. LIF 
treatment of GT1-7 cells resulted in phosphorylation of ERK1/2 and p38, but no changes 
in JNK phosphorylation were observed (Fig. 4.6A). To further delineate the necessity of 
MAPK signaling pathway, co-transfection assays with expression plasmid containing 
constitutively active RAS (CA RAS), that is upstream to the MAPK pathway, resulted in 
repression of GnRH expression by 51.4% (Fig. 4.6B). To identify the MAPK kinase 
pathway sufficient for repression, co-transfection assays were conducted using 
constitutively active forms of MEK1 and MEK2 that leads to ERK1/2 activation, MKK3 
and MKK6 that that activate p38, or MKK4 and MKK7 which activates JNK. 
Constitutively active MEK1, MEK2, MKK4, MKK7 had no effect on GnRH expression. 
GnRH expression was repressed with constitutively active MKK3 and MKK6, which lead 
to activation of p38, by 40.9% and 48.2% respectively (Fig. 4.6C).  
The p38 kinases have four isoforms, p38a, p38b, p38g, and p38s [302]. To explore 
the role of these isoforms on GnRH, constitutively active mutants of p38 isoforms were 
analyzed in co-transfection assays. Reporter activity was repressed by 31% with 
constitutively active p38a, while overexpression of constitutively active p38b, p38g, and 
p38s, had no effect on luciferase activity (Fig. 4.6D).  
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These results demonstrate that LIF represses GnRH transcriptional activity via the MAPK 
pathway, specifically p38, and highlights the important role that p38a plays in this 
repression.  
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Figure 4.6: p38a is sufficient to repress GnRH gene expression. A, LIF treatment 
activates ERK1/2, p38, but not JNK, demonstrated by western blots using whole cells 
lysate of GT1-7 cells treated with LIF for times indicated above each lane. GnRH-reporter 
is repressed by co-transfection with B, constitutively active (CA) RAS; C, CA MKK3 and 
CA MKK6, upstream activators of p38; and D, CA p38a. Statistical significance, p < 0.05, 
indicated by *, was determined with ANOVA followed by Tukey’s post hoc test. 
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cFOS is induced by LIF in GT1-7 cells and represses GnRH  
OCT-1 has been previously identified as an essential regulator of GnRH gene 
transcription [67]. Western blot analysis revealed that OCT-1 protein level was not affected 
by LIF treatment in GT1-7 cells, suggesting that OCT-1 may not mediate LIF repression 
of the GnRH gene. GnRH gene repression by cFOS has previously been shown [291], and 
thus we next examined cFOS protein levels. Indeed, western blots demonstrated that cFOS 
was induced by LIF (Fig. 4.7A). GnRH E/P reporter was repressed by 43.4% with 
overexpression of cFOS (Fig. 4.7B). This indicates that induction of cFOS is likely 
mediating LIF repression of GnRH. 
Several cFOS binding sites were previously identified in the GnRH regulatory 
region [78, 291, 292]. To identify the site involved in LIF repression of GnRH, GT1-7 cells 
were transfected with luciferase reporters containing mutation of the putative cFOS sites 
at -79 in the promoter region (-79m), -1723 (-1723m), -1782 (-1782m), and -1793 (-
1793m) in the enhancer and their expression was compared to wild type GnRH E/P (WT). 
LIF repressed luciferase activity of all reporters used by 61.0%, 61.8%, 65.9%, and 61.6% 
respectively, except of the -1793 mutant, indicating that the mutation of this site prevents 
LIF repression of GnRH (Fig. 4.7C). Thus, the -1793 site is involved in LIF repression of 
GnRH. We confirmed the role of this site by transfecting the mutation of the -1793 site in 
the GnRH E/RSVp reporter and comparing the repression of the mutant to the wild-type 
reporter containing the enhancer linked RSV promoter (GnRH E/RSVp).  
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Similar to what was observed in Fig.4. 7C, LIF repression of GnRH was inhibited with a 
mutation of the -1793 site (Fig. 4.7D). Therefore, LIF induces cFOS which represses GnRH 
gene expression via the -1793 site. 
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Figure 4.7: cFOS mediates LIF repression of the GnRH gene. A, LIF treatment of GT1-
7 cells induces cFOS, but not OCT-1, demonstrated by western blots of nuclear extracts. 
B, Overexpression of cFOS, by co-transfection of cFOS expression vector, is sufficient to 
repress GnRH E/P reporter. * indicates significant difference (p<0.05) determined with 
t-test. C, Mutation of the cFOS binding site at -1793 abolishes LIF repression of GnRH 
E/P reporter, demonstrated by transient transfections of reporters containing the mutations 
of the putative cFOS binding sites in GT1-7 cells. D, the same mutation was created in the 
GnRH E/RSVp reporter and also abrogates the repression by LIF. Statistical significance, 
p < 0.05 indicated by *, was determined with ANOVA followed by Tukey’s post hoc test. 
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cFOS expression is induced with HFD in mice 
 Since we determined that cFOS mediates LIF repression of the GnRH gene and we 
observed reduced GnRH mRNA levels in the hypothalami of mice fed HFD, we explored 
cFOS expression in the hypothalamus. We concentrated specifically in the sections 
containing OVLT where the largest numbers of GnRH neuron soma are found. In the 
hypothalamus of GnRH-GFP mice fed HFD, a significant increase in the percent of double 
labeled green GnRH neurons with cFOS (red) was observed compared to control (CTR) 
(Fig. 4.8A and 4.8B.1). In CTR fed mice, 17.9% of GnRH neurons expressed cFOS, while 
in the HFD mice, 36.3% of GnRH neurons expressed cFOS, suggesting that HFD induces 
cFOS expression in GnRH neurons. To examine specificity of this increase, we also 
counted cells that express cFOS in two other areas, one proximal to OVLT and one more 
dorsal from OVLT, using DAPI to identify cell nuclei. We determined that there is an 
increase in the percent of cFOS positive neurons in the area proximal to the OVLT of mice 
fed HFD (45.4%) compared to CTR (30.5%) (Fig. 4.8A.2, 4.8B.2). However, in the area 
dorsal to OVLT, we did not observe a difference in the number of neurons that express 
cFOS (Fig. 8B.3). Thus, obesity induces cFOS expression in neurons in the proximity to 
OVLT and in GnRH neurons. Given that cFOS mediates LIF repression of the GnRH gene 
in GT1-7 cells, and the reduced levels of GnRH mRNA observed in vivo coupled with an 
increased cFOS expression in GnRH neurons following LIF induction by inflammatory 
stimuli, our data together demonstrate that LIF represses Gnrh mRNA in vivo through 
cFOS. Furthermore, LIF may mediate repression of the Gnrh mRNA and reproductive 
function caused by inflammation.  
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Figure 4.8: More GnRH neurons express cFOS following high fat diet (HFD). A, 
Coronal sections of the preoptic area in the hypothalamus of GnRH-GFP mice following 
HFD stained for GFP (green) and cFOS (red). Scale bar represents 100 µm, white arrows 
indicate GnRH neurons labeled with GFP and cFOS. Numbered squares correspond to 
enlarged areas below; 1, GnRH neurons green, cFOS red; Arrows indicate GnRH neurons 
that express cFOS, an arrowhead points to the GnRH neuron without cFOS; 2-3, DAPI 
channel is included to facilitate cell count; nuclei blue, cFOS magenta. Arrows indicate 
cells labeled with cFOS and DAPI. B, quantification of neurons expressing cFOS in control 
and HFD male mice: 1, increase in the percent of GnRH neurons with cFOS is observed in 
HFD compared to control. 2, quantification of the neurons that express cFOS, proximal to 
the OVLT delineated with  #2 square; 3, quantification of the neurons that express cFOS, 
dorsally from the OVLT delineated with #3 square following control and HFD. Three 
hundred GnRH neurons were counted in each mouse. Statistical significance, p < 0.05 
indicated by *, was determined with t-test. 
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Discussion 
Both infection and obesity negatively affect hypothalamic function, the GnRH 
neuronal network and reproduction, but the mechanisms are unknown. We postulated that 
neuroinflammation is a common characteristic between these conditions and that 
inflammatory cytokines may mediate impairment of reproductive function by both 
infection and obesity. Classical pro-inflammatory cytokines, TNFa, IL1b, and IL-6, are 
induced in the brain during inflammation, when GnRH and LH expression and secretion 
are diminished, but direct regulation of GnRH neuron function by cytokines remain 
inconclusive. In our recently published report [20] and herein, we identified a novel 
cytokine, leukemia inhibitory factor (LIF), which is induced during these inflammatory 
states that directly affects GnRH gene expression. In this report, we also determined the 
precise mechanisms of GnRH gene repression and signaling pathways that are necessary 
for LIF-mediated effects on GnRH neurons. Finally, we demonstrated that the transcription 
factor induced by LIF to repress GnRH gene is increased in a location specific manner 
following HFD in vivo. Repression of Gnrh mRNA expression is consistently observed 
during inflammatory states.  In agreement with previous reports, acute inflammation, 
elicited with an injection of LPS and chronic inflammation, caused by high fat diet (HFD)-
induced obesity, suppresses GnRH mRNA in our studies. LPS treatment, resulting in 
inflammation, represses Gnrh in ewes [303], birds [304] and rats [305]. Infusion of the pro-
inflammatory IL-1b cytokine into the rodent hypothalamus also represses Gnrh expression 
[211].  
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We and others reported that obese mice fed HFD, with a low grade chronic 
inflammation, exhibit lower Gnrh mRNA [20, 188, 210]. These reports suggested that 
repression of Gnrh mRNA during inflammation may be a result of increased cytokine 
concentration. Alternatively, microglia, brain resident immune cells, are involved in the 
regulation of synaptic transmission and activity-dependent structural remodeling [252]. In 
neuroinflammation, in response to injury, infection, or disease, microglia engulf damaged 
synapses [252]. 
We demonstrated decreased synaptic spine density in GnRH neurons following 
obesity-mediated neuroinflammation and microglia activation, indicating reduced 
connectivity [20]. This reduced synaptic activity may regulate Gnrh expression in an 
activity-dependent manner [212, 213]. Some synaptic proteins are regulated in an activity-
dependent manner at the transcriptional level [306]. This may be the case with GnRH gene 
expression as well, since several hypothalamic factors, such as RFamide-related peptide 3 
(RFRP-3), a mammalian gonadotropin-inhibitory hormone ortholog; senktide, a 
neurokinin B receptor agonist; and oxytocin; alter both GnRH secretion and Gnrh 
transcription [214-216]. However, since GnRH neurons express cytokine receptors [157], 
herein, we investigated if Gnrh gene is repressed via activation of cytokine receptor 
signaling pathways. 
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We identified LIF as a critical player in the neuroinflammation-induced impairment 
of GnRH gene expression. In the brain, LIF is involved in neural stem cell maintenance 
and axonal growth, and in modulation of gene expression [307]. During embryonic 
development, LIF is expressed in the olfactory placode, which led to the hypothesis that 
LIF affects GnRH neuron migration [276]. Our results demonstrate that LIF represses 
GnRH gene expression, which is in agreement with findings that GnRH mRNA is 
repressed during embryonic GnRH neuron migration [308], in addition to repression during 
inflammation. To analyze the effects of infection on GnRH, previous studies analyzed 
classical inflammatory markers, TNF-a, IL-1b and IL-6, but not LIF. Although LPS, or 
TNF-a or IL-1b administration in the ventricle consistently reduces GnRH secretion in 
vivo [154-156, 262], some have found that IL-6 treatment of the hypothalamic slices 
stimulates GnRH secretion [263, 309]. While IL-1a and TNF-b are prototypical pro-
inflammatory cytokines, IL-6 may function as either a pro- or anti-inflammatory cytokine 
depending on timing and stimulus. IL-6 synthesis in the hypothalamus is induced by IL-1b 
[310], and may be engaged in the negative feedback to dampen inflammation [274]. Thus, 
results may vary due to the differences between in vivo and in vitro treatments, since 
initially-induced cytokines may cause a cascade of other cytokines in vivo. For this reason, 
we concentrated on analyzing the effects of LIF in GT1-7 cells. LIF alone repressed Gnrh 
mRNA and GnRH reporter, similarly to HFD-induced and LPS-elicited repression of 
GnRH mRNA in vivo.  LIF is induced by IL-1b in vivo.  Therefore, IL-1b repression of 
GnRH mRNA, demonstrated in previous studies, may occur via induction of LIF.  
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We determined that LIF induces cFOS which represses GnRH gene expression. 
GnRH repression by cFOS has been demonstrated previously and several cFOS binding 
sites have been identified in the GnRH regulatory region [291, 292]. However, a specific 
site necessary for GnRH repression has not been identified, until now. GnRH gene is 
inhibited by PKC signaling pathway, which induces cFOS [76, 290]; and PKC activation 
by TPA treatment represses GnRH gene via the -1793 site [78]. Here we demonstrate that 
this same site at -1793 is involved in LIF repression of the GnRH gene. This site is 
juxtaposed to the OCT-1 binding site, and OCT-1 is the critical transcription factor that 
regulates GnRH gene expression [67, 70, 78, 311]. Thus, although OCT-1 protein levels 
do not change with LIF treatment, its interaction with cFOS [312], likely modulates that 
level of GnRH gene expression. 
Signaling pathways involved in the regulation of GnRH gene transcription by 
cytokines have not been elucidated. GP130, the common signal transducer for IL-6 and 
LIF family, is expressed in GnRH neurons in vivo. LIF treatment activates STAT3 in 
GT1-7 cells, a model of mature GnRH neurons, as we show herein, and in GN11 cells, a 
model of immature, migrating GnRH neurons [276]. However, to exert its effect on GnRH 
gene expression, LIF activates MAPK-p38 pathway, and in particular p38a is critical for 
this effect. This is an important finding, since while other p38 isoforms have normal 
physiological functions, p38a is involved in inflammatory processes [313]. Moreover, 
p38a is the target for several potential therapeutics for chronic inflammatory disorders.  
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Leptin is necessary for pubertal transition and normal reproductive function [314, 
315]. Since leptin is elevated in obese and HFD-fed mice, leptin was previously analyzed 
as a mediator of obesity-induced impairment of reproductive function [111, 208, 258]. 
Additionally, a mouse model with leptin overexpression exhibits early puberty and lower 
GnRH at 21 weeks of age [316], which may correlate with precocious puberty in obese 
girls and lower Gnrh mRNA in obese mice in our study. However, previous studies 
determined that leptin does not directly affect GnRH neurons in vivo, since deletion of the 
leptin receptor specifically in GnRH neurons has no effect on fertility [101]. STAT3 
signaling molecule, activated by leptin, is required for leptin’s role in energy balance, on 
the other hand, it is not required for leptin’s effect on fertility [317, 318]. Therefore, 
regardless of the metabolic dysfunctions in STAT3 mutant mice, reproductive functioning 
remained unaffected, demonstrating a clear separation in roles for each signaling pathway. 
Although leptin receptor is similar to the IL-6 and LIF signaling receptor, GP130, and can 
activate the same signaling pathways, leptin does not engage GP130 [319]. Taken together, 
it is unlikely that elevated leptin levels in our studies had direct effect on GnRH gene 
expression. 
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We demonstrate that cFOS expression is increased specifically in GnRH neurons 
and in cells located close to the OVLT, but not in cells located more dorsally, following 
HFD. Others reported increased cFOS following HFD in specific areas and postulated that 
the location is specific for the function of the neuronal population. For example, cFOS was 
increased in the reward circuitry following HFD [320] and in the dorsomedial and lateral 
hypothalamus [321]. cFOS is similarly induced following LPS treatment in the 
hypothalamus [322] and this induction is location specific [323]. These studies further 
postulated that the location is dependent on the function of the neurons. We, on the other 
hand, posit that it is dependent on the proximity to the vasculature. Previous studies also 
suggested that cFOS was induced following neuron activation, since cFOS is most 
commonly used marker of neuronal activity. As an immediate early gene, cFOS is induced 
via activity-dependent transcription in neurons. cFOS expression is increased in activated 
GnRH neurons as well, during the preovulatory LH surge and after kisspeptin treatment 
[324, 325]. The roles of cFOS as a transcription factor, involved in the GnRH gene 
regulation, and as a marker of neuronal activity, are not mutually exclusive. Thus, we 
postulate that increased LIF concentration induces cFOS specifically in GnRH neurons to 
repress GnRH gene expression. Specificity for GnRH neurons may be due to either their 
proximity to the OVLT or because GnRH processes extend beyond the blood brain barrier 
into the OVLT.  
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Our studies delineate the mechanisms of neuroinflammation impairment of GnRH 
gene expression and may explain repression of reproductive function during infection and 
in obesity. We identified LIF as the cytokine that mediates these effects and p38a as a 
critical signaling molecule. We also postulate that the proximal location of GnRH neurons 
to the leaky blood brain barrier, where the local concentration of this cytokine may be the 
highest, permits for repression of GnRH gene expression via cFOS induction. Future 
studies will determine in vivo role of p38a in neuroinflammation-mediated GnRH 
repression.  
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Chapter 5: Conclusion 
My dissertation research identified mechanisms of obesity-mediated impairment of 
reproduction function and identified profound sex differences in responses to high fat diet 
(HFD). My work determined that male C57BL/6J mice are prone to diet-induced obesity 
(DIO) with HFD, and experience profound neuroendocrine and inflammatory changes 
when obese. Male mice exhibit chronic inflammation and high levels of cytokines in the 
circulation and in the hypothalamus that are locally produced. On the other hand, female 
mice are resistant to DIO. Loss of ovarian hormones, after ovariectomies, made females 
susceptible to DIO. This is in agreement with previous studies using rodent and primate 
animal models and with finding in human population where women gain weight after 
menopause. My studies determined further that although ovariectomized female mice gain 
weight similarly to males, they remained resistant to neuroendocrine changes and 
inflammatory changes, showing that ovarian hormones are not necessary for this 
protection. My results challenge the long accepted protective role of ovarian estrogen in 
neuroendocrine and neuroinflammation in females and identify that the female immune 
system responds differently to DIO compared to males. Females have higher levels of the 
anti-inflammatory cytokine IL-10 than males at the basal level, and the difference is 
exacerbated with chronic inflammation in obesity. Thus, females are resistant to chronic 
inflammation regardless of the gonadal status. 
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Males, but not females, exhibited reduction in reproductive hormones in all levels 
of the hypothalamic-pituitary-gonadal axis, lower GnRH expression in the hypothalamus, 
diminished levels of gonadotropin hormones, LH and FSH, from the pituitary and reduced 
levels on testosterone from the testes. Since all levels of the HPG are similarly affected, 
hypothalamus and GnRH neuron network are the likely primary site of dysregulation. My 
results, indeed demonstrate decrease in the levels of post-synaptic density, 95, protein in 
the hypothalamus, and reduced spine density in GnRH neurons. Microglial activation and 
peripheral macrophage infiltration is seen in the hypothalami of males, and both can 
contribute to synapse elimination in neuroinflammation. As explained in chapter 1, GnRH 
neuron activation requires stimulation by a pulse generator since they are scattered in the 
hypothalamus. Therefore, it is possible that the reduced spine density illustrates reduced 
afferent neuron connectivity to GnRH neurons, which will be analyzed in future studies. 
Thus, reduced activity of GnRH neuronal network may be responsible for diminished 
levels of gonadotropin hormones, testosterone, and sperm numbers, which corresponds to 
the observations in obese humans. 
Additionally, neuroinflammation-induced cytokines can directly regulate GnRH 
gene expression. Previous studies have demonstrated that both states of inflammation, 
acute, induced with LPS injection or the central administration of cytokines in the mouse, 
and chronic, observed in obesity, have resulted in reduced levels of GnRH mRNA, but the 
mechanism was unknown. I determined that LIF cytokine that is increased with both acute 
inflammation, by LPS injection, and chronic inflammation, by DIO, repressed GnRH gene 
expression. I examined LIF signaling pathways and mechanisms of GnRH repression in 
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vivo and in GnRH-expressing cell line, GT1-7.  LIF activates MAPK pathway, specifically 
p38a, and induces cFOS to represses GnRH gene, mediated via the -1793 site in the 
enhancer region. In vivo, following HFD, cFOS is induced in GnRH neurons and neurons 
juxtaposed to the leaky blood brain barrier of the organum vasculosum of the lamina 
terminalis, but not in the neurons further away. Our results indicate that the increase in LIF 
due to neuroinflammation induces cFOS and represses GnRH gene. Therefore, in addition 
to synaptic changes in GnRH neurons, neuroinflammatory cytokines directly regulate gene 
expression and reproductive function. 
Taken together, our data implicate neuro-immune mechanisms underlying sex-
specific differences in obesity-induced impairment of the hypothalamic function with 
potential consequences for reproduction and fertility.  
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